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Th e lacrimal apparatus is responsible for producing the three-layered tear fi lm which 
protects the eye surface. Th e tear fi lm external or lipid layer is produced by the meibomian 
glands (MGs) located in the eyelid. Th e middle layer, or aqueous layer is the most abundant 
and is synthesized by the lacrimal gland (LG), localized in the orbit. Th e last layer is the 
internal or mucous layer, secreted by the goblet cells distributed within the conjunctival 
epithelium. Specifi cally, the aqueous component is the main source of growth factors 
destined to the avascular cornea. Th ose are necessary for corneal epithelium maturation 
and subsequent renewal. 
A defective tear fi lm leads to dry eye diseases (DEDs) aff ecting an increasing percentage of 
the population (more than 35% in the elderly). Although DEDs can lead to visual loss in 
extreme cases, no defi nitive treatment has been developed so far.
LG is a branched ectodermal organ, which starts to develop around embryonic day 
(E)13.5-E14 in mouse. Around E15, an epithelial bud invaginates into a mesenchymal 
capsule. Branching morphogenesis starts around E16 and continues in postnatal stages. 
In adult LG, the epithelium can be divided in three compartments: the acini, synthesizing 
the majority of LG fl uid; the ducts, modifying its composition; and the myoepithelial 
cells (MECs), with contractile functions. LG maturation occurs in postnatal stages, 
and is concomitant with dynamic gene expression changes, necessary for cell terminal 
diff erentiation and ipso facto LG function.
In my thesis work, I fi rst focused on the basis of LG morphogenesis, delineating early 
molecular and cellular events implicated in its formation. I characterized LG epithelium 
growth and patterning by investigating cell proliferation and gene expression profi les. 
I highlighted a major LG epithelial outgrowth around postnatal day (P)7, before the 
beginning of cornea stratifi cation (around P10) and the eyelid opening occurring between 
P12-P14.
LG is known to play a role in corneal biology, notably during the wound healing process by 
secreting growth factors in the tear fi lm. I studied the relationship between LG and cornea, 
fi rst participating to the establishment of a reliable model to follow mouse corneal re-
epithelialization aft er mechanical abrasion. Th is showed that the cornea heals within three 
days aft er the injury. 
To go further, I used this abrasion model to study the communication between LG and 
cornea in a pathophysiological situation. I used X-linked Ectodermal Dysplasia (XLHED), 
resulting from an Eda loss-of-function mutation and leading to dry eye symptoms in 
human, to investigate LG-cornea interaction in a dry eye context. As the eff ect of Eda-/- 
XI
mutation on LG biology were unclear, I fi rst demonstrated the important role of Eda 
pathway in LG maturation and physiological functions. Next, I studied the impacts of LG 
maturation defects on cornea healing process and showed an altered gene regulation in 
Eda-/- LG in response to corneal injury. Moreover, I showed that Eda pathway gets inhibited 
in both LGs following corneal abrasion, further indicating a sophisticated cross-talk 
between bilateral LGs and the wounded cornea.
In addition of improving the general knowledge on LG biology, my work participated 
to shed a new light on the aetiology of XLHED-associated dry eye and on the resulting 
defective cornea wound healing.
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RESUME (en français)
L’appareil lacrymal est responsable de la production du fi lm oculaire protégeant la cornée. 
Le fi lm oculaire est composé de trois couches. La couche externe ou couche lipidique est 
secrétée par les glandes meibomiennes, situées dans les paupières. La couche intermédiaire 
ou couche aqueuse est produite par la glande lacrymale, localisée dans l’orbite. Cette 
portion aqueuse représente la majeure partie du fi lm oculaire. La cornée ne possédant pas 
de vaisseaux sanguins, la partie aqueuse est aussi l’unique source de facteurs de croissance 
nécessaires à la maturation et au maintien de l’intégrité de celle-ci. Pour fi nir, la couche 
interne ou partie muqueuse est secrétée par les cellules à goblet, localisées sur la conjonctive. 
La glande lacrymale est un organe ectodermique branché dont le développement 
commence aux alentours du jour embryonnaire (E)13.5-E14 chez la souris. A E15, la 
glande lacrymale est séparée en un bourgeon épithélial s’invaginant dans un mésenchyme. 
Le branchement de l’épithélium commence vers E16 et continue après la naissance. Chez 
la souris adulte, la glande lacrymale possède trois compartiments : les acini, produisant la 
majeure partie du composant aqueux ; les canaux, modifi ant cette sécrétion, et les cellules 
myoépithéliales, sécrétant la lame basale, nécessaire à l’intégrité structurelle de la glande, et 
ayant des propriétés contractiles importantes à l’excrétion du fl uide produit.
La glande subit une étape de maturation pendant les stades postnataux. Cette maturation se 
traduit par des changements d’expression génique conduisant à la diff érentiation cellulaire 
terminale.
Dans mon projet de thèse, j’ai premièrement créé des outils indispensables pour l’étude 
du développement embryonnaire de la glande lacrymale. Je me suis intéressée à la 
caractérisation de sa formation précoce, ainsi qu’à sa maturation. De plus, j’ai étudié la 
glande lacrymale dans une situation pathologique, dans le cas de la dystrophie ectodermique 
liée à l’X. Ce syndrome est retrouvé chez l’homme, et est associé à des symptômes d’œil sec. 
J’ai mis en évidence le défaut de maturation des glandes lacrymales présentant une perte de 
fonction du gène Ectodysplasine (Eda), et j’ai fait le lien avec une réduction de leur fonction. 
La production de protéines par la glande lacrymale à la suite d’une blessure de la cornée est 
nécessaire à la réparation de l’épithélium cornéen. Par la suite, j’ai participé à l’élaboration 
d’un protocole d’abrasion de la cornée et l’ai utilisé afi n d’étudier le dialogue cornée-
glande lacrymale. Dans l’ensemble, mes travaux de thèse ont permis de faire avancer les 
connaissances générales sur la glande lacrymale, ainsi que sur la communication établie 
entre la cornée et la glande lacrymale .
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1.  REVIEW OF THE LITERATURE
1.1.  Lacrimal func  onal unit morphology and func  on
1.1.1.  Overview
About 360 million years ago, the transitional period initiating the terrestrialisation of 
crossopterygian fi sh gave rise to the fi rst amphibians. Among the adaptations required to 
survive in their new habitat, protection of the eye surface from the dry aerial environment 
became instrumental for clear sight. Th e adaptation of specialized glands to the production 
of the tear fi lm was the key to maintain the eye surface moist (Murube 2009). 
Th e tear fi lm is composed of three layers, namely lipid or external layer; aqueous or 
middle layer and mucous or internal layer. Th ese three diff erent layers are mainly produced 
respectively by the meibomian glands (MGs), the lacrimal glands (LGs) and the goblet cells 
(fi gure 1). Lastly, harderian glands lubricate the nictitating membrane or third eyelid. Th e 
nictitating membrane is present in almost all mammals but in higher primate species and 
will not be described here. Overall, the lacrimal apparatus produces tears that are drained 
into the conjunctival sac via the puncta (fi gure 2) (Orge and Boente 2014). 
Th e lacrimal fi lm has both nutritional and protective (physical and anti-microbial) 
properties (Tiff any 2008) It is 3μm thick in human but thicker in the mouse, on average 
7μm (King-Smith et al. 2000; Wang et al. 2003; Johnson and Murphy 2004). 
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Figure 1: Th e tear fi lm. Th e lacrimal apparatus is constituted of three compartments: the 
meibomian glands (orange) are localized in the eyelids and secrete the lipid layer of the tear 
fi lm. Th e lacrimal gland (blue) is located in the orbit and produces the aqueous layer. Th e goblet 










Figure 2: Tear distribution on the ocular surface. Th e lacrimal gland (LG) produces most of 
the tear fl uid. In human, the LG is separated into two lobes – the palpebral and the orbital lobes, 
anatomically close from each other. Th e lacrimal fl uid is distributed (red arrows) on the ocular 
surface due to eyelid movements and the presence of a tear meniscus. Subsequently, the tear 
fl uid is collected and drained through the upper and lower puncta into the lacrimal sac via the 
lacrimal canaliculi. Modifi ed from (Holly and Lemp 1977).
1.1.2.  Meibomian glands
MGs are sebaceous glands distributed within the eyelids. In human, upper eyelids contain 
roughly 25 glands, and lower eyelids about 20 glands (fi gure 1). Each gland is composed 
of a long canal encircled by multiple lipid-producing acini (Obata et al. 1994; Obata 2002). 
MG histological and secretory functions are very similar in mouse and human (Butovich 
2017).
MGs are responsible for the production of the lipid layer of the tear fi lm, or meibum 
(Paulsen and Berry 2006), mainly composed of polar and nonpolar lipids (McCulley 
and Shine 2003; Butovich 2017). Phospholipids are the predominant polar lipids; while 
nonpolar lipids are represented by a mixture of cholesterol, cholesterol esters, and wax 
esters. Meibum is liquid at eyelid temperature, with a melting range between 19.5 and 
32.9°C (Foulks and Bron 2003).
Directly in contact to the environment, the lipid layer protects the tear fi lm from 
evaporation, enhances its stability and spreading, and creates a barrier to prevent from 
contaminations.
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It is thought that a stable interaction between the lipid and aqueous layers requires the 
interaction between polar lipids from the lipid layer side, and lipophilic proteins (such as 
lipocalins) from the aqueous layer (Foulks and Bron 2003).
1.1.3.  Main and accessory LGs
Th e main LG is an almond-shaped tubulo-acinar gland with secretory functions, divided 
in two lobes, and responsible for the production of the tear fi lm aqueous layer. Interspecies 
diff erences exist between LGs of human, rabbit and rodent (including mouse and rat) (for 
review, (Schechter et al. 2010)). It seems that all species share the two-lobed LG feature. 
Nonetheless, the localization of the main lobe varies. In rodent and in some monkey 
species, a small lobe is found in the orbit and a bigger one is located away from the eye, 
close to the ear region (Veiga Neto et al. 1992) (fi gure 3). Human and rabbit species have 
both lobes in the orbit. Th e human orbital lobe is the biggest one, localized in the lacrimal 
fossa of the frontal bone (Lorber 2007; Orge and Boente 2014). Th e smaller palpebral lobe 
is located in the superolateral region of the eyelid, underneath the tendon of the levator 
palpebrae superioris muscle (fi gure 2) (Paulsen and Berry 2006). 












Figure 3: Th e murine lacrimal gland. Th e murine lacrimal gland (LG) is divided into two 
lobes away from each other. Th e intra-orbital lobe is close to the eye; the extra-orbital lobe 
(EOL) develop away from the eye, close to the ear region. LG epithelium is divided into three 
compartments. Th e ducts, participating to the LG fl uid composition, are formed by cuboid 
cells (1). Th e myoepithelial cells (MECs, 2) secrete the basal membrane and have contractile 
functions. Th e acini are responsible for the production of the majority of LG fl uid. Th ey are 
composed of acinar cells, which contain a large number of secretory vesicles (3). During fl uid 
excretion, the secretory vesicles fuse with the apical side of the acinar cell membrane and release 
their content into the lumen of the ducts.
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Despite the location diff erences, the LG histological structure is conserved. Each lobe is 
divided into lobules, separated from each other by loose connective tissue, composed of 
extracellular matrix (secreted by fi broblasts), nerves, and blood vessels (Obata 2006). Th e 
tear product is delivered onto the eye surface via lacrimal ducts: one fi nal duct in the mouse 
compared to numerous (6 to 12) in human (Lorber 2007).
Along with the main LG, in human, LG accessory glands (glands of Wolfring 
and Krause) are localized in the palpebral conjunctiva and in the conjunctival fornix, 
respectively (Chastain and Sindwani 2006; Lorber 2007; Kels et al. 2015). LG accessory 
glands are considered to have similar structures and functions to the main LG and 
participate for about 10% of the tear production (Orge and Boente 2014). 
Th e mature LG is commonly formed of three distinct domains: acinar, myoepithelial 
and ductal compartments, each having a role in the production, modifi cation and excretion 
of the LG fl uid (fi gure 3).
Acini are composed of pyramid-shaped acinar cells with a central lumen (Obata 
2006). Th ey represent around 80% of the LG volume (Schechter et al. 2010) and secrete the 
majority of the proteins, electrolytes, water and other constituents composing the aqueous 
part of the tear fi lm (Obata 2006). Basic histoarchitectural features (acinus ultrastructure 
and stromal compartment), appear to be the main diff erences between rodent and human 
LGs. Th e rodent LG depicts tightly compacted lobules and narrow lumen in the acini, while 
the human one has looser lobules, and larger lumen. Although rabbit LG has been reported 
to better match the human LG histoarchitecture, the functional aspects related to protein 
composition, production and secretion, seem to be conserved in human, rodent and rabbit 
LGs (Schechter et al. 2010). Th ese species share a common heterogeneity in the acinar 
secretory vesicles, produced by both serous and mucous acinar cells in variable proportion. 
Th is observation defi nes the LG as a seromucous organ (Schechter et al. 2010).
Myoepithelial cells (MECs) are stellate and multi-processed cells with contractile 
functions, located around the acini. Th ey maintain acinar integrity, secrete the basal 
membrane components and participate to acinar production excretion (Makarenkova and 
Dartt 2015).
Finally, ducts participate to LG fl uid modifi cation and secretion (Katona et al. 2014; 
Vizvari et al. 2016; Berczeli et al. 2018). Particularly, ductal cells are water permeable and 
exhibit ion channels acting on LG fl uid osmolarity.
1.1.4.  Goblet cells, conjunctival and corneal epithelium
Goblet cells are secretory cells distributed all over the conjunctival epithelium (fi gure 1). 
Th ey are responsible for producing the majority of the tear fi lm mucous or internal layer of 
the tear fi lm (Takahashi et al. 2013). Th e mucous layer forms a soluble surfactant necessary 
to distribute the water on the whole eye surface (Holly and Lemp 1977) and represents a 
barrier against pathogens. 
Amongst species, conjunctival goblet cells have similar functions but a variable 
distribution pattern. In human, goblet cells can be observed both as individuals as well as 
in clusters and the density is higher in the nasal region of the conjunctiva. Contrastingly, 
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mouse goblet cells are mainly found distributed as clusters all over the conjunctiva (Gipson 
2016).
Although only the goblet cells are capable to supply a suffi  cient amount of soluble 
surfactant, various other cells are capable of producing mucins. Th ese include conjunctival 
and corneal epithelial cells, and to a lesser degree the main and accessory LG acinar and 
duct cells (Paulsen et al. 2003). 
Mucins, a general term for high molecular weight glycoproteins, form a hydrophilic 
layer on the eye surface. Two types of mucins can be found in the internal layer of the 
tear fi lm: secreted and membrane-bound mucins. Goblet cells produce the majority of the 
secreted mucins, while conjunctival and corneal epithelial cells produce the membrane-
bound ones. 
Mucins dissolve partially in the aqueous layer, making it diffi  cult to separate both layers 
(Takahashi et al. 2013). Finally, the glycocalyx, secreted by the surface corneal epithelial 
cells, forms a scaff old of long chain molecules binding and stabilizing the mucous layer at 
the corneal surface (Gipson 2004).
1.2.  Spotlight on the eye
1.2.1.  Overview
Th e human and mouse eyes are camera type eyes, which can be divided into the anterior 
and the posterior segments. Th e anterior eye segment comprises cornea, iris (separating the 
anterior and posterior chambers), ciliary body and lens (fi gure 4). Th e cornea represents 
the avascular transparent layer in contact with the external environment and covered by the 
















Figure 4: Th e human eye. Th e human eye is composed of the anterior and the posterior 
segments. Th e anterior eye segment notably includes the cornea, iris and lens. Th e cornea is 
formed by three compartments: the stratifi ed squamous epithelium (5 to 6 cell layers), the 
stroma and the endothelium. Th e Bowman’s membrane separates the stratifi ed epithelium 
from the stroma and the Descemet’s layer lays in between the stroma and the endothelium. Th e 
stroma is secreted by the stromal keratocytes. Th e retina and the optic nerves are part of the 
posterior eye segment.
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tear fi lm. Together with the lens, they form a single optical element, and are instrumental to 
light focusing onto the retina.
Finally, the posterior eye segment, which will not be described here, is composed of 
vitreous humor, choroid, retina and optic nerve.
1.2.2.  Eye morphogenesis
In early development, one of the three embryonic layers, the ectoderm, diff erentiates into 
the surface ectoderm and the neurectoderm (subsequently giving rise to the neural crest and 
the neural tube) (fi gure 5). Th e fi rst eye structures originally derive from the neurectoderm, 
producing both the neural crest and the neural tube. Th e neural tube will form the optic 
vesicle, invaginating to become the optic cup. Th e optic cup is responsible for the formation 
of the retina, ciliary body and iris. In parallel, the surface ectoderm interacts with the 
underlying structures and transforms into the diff erent cranial placodes, depending on the 
molecular signals received. Th e cranial placodes gather the oral, olfactory, lens and corneal 
epithelium (CE) placodes. In absence of signal however, the surface ectoderm leads to the 
epidermal fate (for review, (Dhouailly et al. 2014)).
Th e diff erent steps resulting in cornea development are conserved among species, but 
the timeline diff ers. For simplicity, only human and mouse timelines are described here. 
Current understanding is that the CE and lens placodes derive from surface ectoderm 
common eye precursors, and that CE presumptive territory becomes specifi ed upstream 
the lens. 
Th e optic vesicle sends positive signals to the above specifi ed CE. Th is results in 
CE-derived committed lens placode, which invaginates to form the lens vesicle before 
detaching from the remaining CE. Subsequently, a wave of neural crest cells (NCC) migrates 
between the lens vesicle and the CE and forms the corneal endothelium along with the 
stromal fi broblasts, secreting the corneal stroma. NCC-derived endothelial cells produce 
necessary lens-suppressing signals directed to the overlaying specifi ed CE, stabilizing CE 
fate over lens diff erentiation. 
In mouse, CE and lens placodes arise around E8 (fi gure 5). Th e lens placode is 
specifi ed by embryonic day (E) 10 and the presumptive CE can be observed at E11.5, laying 
above the lens vesicle. Th e NCC migration wave occurs between E12 and E14. By E15.5, the 
three corneal elements, i.e. CE, stroma and endothelium are already in place. At birth, the 
CE is composed of 1-2 cell layers (for review, (Swamynathan 2013)). 
In human, the optic precursors arise around the fourth week of gestation. Th is 
corresponds approximately to stages 12-13 in the Carnegie classifi cation by Ronan 
O’Rahilly (Gasser et al. 2014). By the end of the fourth week of gestation, the optic vesicle 
lies underneath the surface ectoderm. Subsequently, by the sixth-seventh week (stages 
17-20), the lens is mostly formed, and CE commitment occurs. Cornea development 
takes place during the seventh and eight weeks of gestation (stages 18-23). CE, stroma and 
endothelium are formed by the end of the eighth week of gestation (stage 23) (Pearson 
1980).
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1.2.3.  Cornea postnatal maturation, renewal and regeneration
Th e mature cornea is formed by three compartments: a stratifi ed epithelial outer layer, 
a stroma and an endothelial inner layer. In human and mouse, the stratifi ed epithelium, 
the stroma and the endothelium are separated from each other by a basal membrane (the 
Bowman’s membrane and Descemet’s layer, respectively) (Kels et al. 2015) (fi gure 4). In 
mouse, the presence of a Bowman’s membrane remains however controversial. 





























Figure 5: Eye development in mouse. Between E8 and E10, the optic vesicle sends positive 
signals to the above specifi ed corneal epithelium (CE) to give rise to the lens placode. 
Subsequently at E10.5, the lens placode invaginates and forms the lens vesicle by E11. Between 
E12-E14, neural crest cells (NCCs) migrate between the lens vesicle and the CE to form the 
presumptive corneal endothelium and stroma by E15.5. At birth, the CE is composed of 1-2 cell 
layers, and stromal keratocytes secrete the stromal components. In postnatal stages, stratifi cation 
results in the stratifi ed CE by 6 wo. SE: surface ectoderm. Modifi ed from (Swamynathan 2013). 
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At birth in the mouse, CE is composed of 1-2 cell layers. In this specie, eyelid opening 
only occurs between postnatal day (P) 12-14, subsequently aft er the beginning of cornea 
stratifi cation (P10) (Zieske 2004; Zhang et al. 2015). During this period, rapid cell 
proliferation results in a 5-6-layered CE by 3 weeks old (wo) and in a 6-8-layered squamous 
epithelium by 8-10 wo. Cornea maturation timeline observes tremendous diff erences 
between species. While in human, eyelids are already opened in the womb and the time of 
fully mature cornea has not been established (however occurring aft er birth), the cornea 
appears fully mature aft er the two fi rst weeks of embryogenesis in chick embryo and around 
P12 in rabbit. Strikingly in mouse, the CE reaches full maturity only 6-7 months aft er birth 
(for review, (Dhouailly et al. 2014)). In the mouse, cornea maturation is assisted by LG 
growth factors secretion (Zieske 2004). It is however unclear if this would be the case in 
human, as cornea maturation time has not been rigorously established, and LG maturation 
occurs around 6 wo.
Corneal maturation can be followed by the expression of Keratin19 (Krt19), high in 
embryonic CE but decreasing in postnatal stages (Kalha et al. 2018b). In addition, the 
diff erentiated central CE can be recognized by the expression of Krt3/Krt12 (KRT3/KRT12 
forming a pair) in numerous species but in the mouse, in which only Krt12 is expressed 
in the mature CE (Chaloin-Dufau et al. 1993). Th e corneal SC niche or limbus localizes in 
periphery at the border between cornea and conjunctiva (Schermer et al. 1986). In contrast 
to the central CE, the adult limbus is overall marked by KRT19 (Kalha et al. 2018b), and 
the presence of KRT5/KRT14 pair in its basal layer. Moreover, Krt15 was recently reported 
as a specifi c marker for mouse limbal cells (Nasser et al. 2018). In human, the limbus is 
formed by the palisades of Vogt, which are undulated regions forming crypts (for review, 
(Dhouailly et al. 2014)). In the mouse, however, no crypts can be detected. Nonetheless, 
recent fi ndings demonstrated that upon limbal injury, central corneal-committed cells 
could dediff erentiate in order to repopulate the limbus area and form Krt15-expressing 
limbal SCs-like cells (Nasser et al. 2018). Besides, from birth to adulthood, mouse CE has 
been shown to be renewed by local pools of progenitors which are replaced by limbal SCs 
every 4 to 8 weeks (Kalha et al. 2018b). Together these fi ndings highlight the important 
adaptive capacities of the cornea.
1.2.4.  Cornea innervation
In all mammals, the major type of corneal nerve fi bres are sensory aff erent projections, 
mainly deriving from the ophthalmic division of the trigeminal nerve (for review, (Muller 
et al. 2003)). Th ese nerves transduce any chemical, mechanical or thermal stimuli from the 
cornea to the central nervous system to ensure the maintenance of a healthy environment 
for the CE. Th ese stimuli refl ect for example the ocular dryness or possible external hazards 
(Yang et al. 2018). To a lesser measure, the cornea receives sympathetic innervation, 
coming from the superior cervical ganglion. In some mammals, corneal parasympathetic 
innervation arises from the ciliary ganglion, but there is up to date no evidences in human 
(Muller et al. 2003). 
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In the mouse, no innervation can be detected in the eye anterior segment at E11.5. 
Th e innervation of the cornea area begins by the stroma around E12.5-E13.5 in the mouse 
(for review, (Lwigale 2015)). Th e fi rst nerves to appear are the aff erent projections of the 
trigeminal nerve’s ophthalmic branch and they arise from the four quadrants of the eye, i.e. 
dorsal-temporal, dorsal-nasal, ventral-temporal, and ventral-nasal quadrants. Th e secretion 
of axon guidance molecules (such as semaphorins) in the lens underlying the cornea have 
been reported to be necessary for proper patterning of the corneal nerves (Lwigale and 
Bronner-Fraser 2007). 
Th e fi rst signs of CE innervation are however only detected at E16.5 (McKenna and 
Lwigale 2011), when the stromal compartment is already fully innervated. At this stage, each 
projection or nerve bundle from the stromal compartment repeatedly ramifi es into smaller 
branches as it projects perpendicularly to the corneal surface to reach the central CE. Th is 
ramifi cation occurs concomitantly to CE stratifi cation, in postnatal stages (fi gure 6). 
Around P21, all nerve bundles form a sub-basal plexus within the stroma and 
subsequently invade the central cornea forming epithelial leashes. Th is results in a swirl 
pattern which is visible from birth to adulthood. Th is swirl pattern is also found in adult 
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Figure 6: Innervation of the cornea. During corneal epithelium (CE) stratifi cation, the nerve 
bundles localized in the stromal compartment travel perpendicularly through the Bowman’s 
membrane and penetrate the CE. Th e nerves axons ramify into smaller branches to reach the 
corneal surface and colonize the diff erent layers of the squamous stratifi ed CE. Modifi ed from 








human (Patel and McGhee 2005; Marfurt et al. 2010). Th is is however not common to all 
species. Th e timeline of innervation varies from mouse to human, but the diff erent steps 
remain similar in both species. In human, roughly 30 nerves can be detected in the stroma 
at 3 months aft er birth (McKenna and Lwigale 2011). 
1.3.  Spotlight on the lacrimal gland 
1.3.1.  LG morphology
1.3.1.1.  LG embryonic development
Similarly to other ectodermal organs, including salivary, sweat and mammary glands, LG 
initially develops from a thickening of an epithelium in result to an interaction epithelium-
mesenchyme (for review, (Yao and Zhang 2017)). Th e conjunctival epithelium, derived 
from the surface ectoderm, represents the LG origin (Makarenkova et al. 2000; Orge and 
Boente 2014). 
In the mouse, LG formation begins around E13.5-E14 (Makarenkova et al. 2000). An 
epithelial bud invaginates in a mesenchymal capsule at the temporal edge of the eye around 
E15 and by E16, branching morphogenesis results in the formation of elongated branches 
with terminal end buds (TEBs) (Yao and Zhang 2017). Branching morphogenesis continues 
in postnatal stages (Makarenkova and Dartt 2015) (fi gure 7). 
In human, LG early formation happens around the seventh week of gestation (Carnegie 
stages 19-20) (de la Cuadra-Blanco et al. 2003). LG ducts are formed later, at about 12 
weeks of gestation. Human LG development can be divided into three stages: presumptive 
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Figure 7: Mouse lacrimal gland embryonic development. Lacrimal gland (LG) development 
timeline diff ers according to the genetic background of the mouse, but the diff erent steps are 
identical from one wild-type strain to the other. For clarity, the timeline depicted here is the one 
for the ICR mouse strain. LG extra-orbital lobe (EOL) formation initiates around E14 with the 
invagination of the conjunctival epithelium in a mesenchymal capsule. At E15, the primary bud 
(epithelial compartment, blue) elongates in the mesenchymal compartment (yellow). Branching 
morphogenesis starts around E16, forming terminal end buds (TEBs) and continues aft er birth. 
At E17, the intra-orbital lobe sprouts close to the eye, from the duct in elongation.
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glandular (stages 19-20), epithelial bud (stages 21-23) and glandular maturity stages (9-16 
weeks of gestation). Despite a fully formed LG at birth, the mature excretory functions are 
only acquired postnatally, during the fi rst 6 weeks of life (Paulsen and Berry 2006; Orge and 
Boente 2014).
1.3.1.2.  LG postnatal maturation
Postnatal observation of MEC and acinar compartments reveals a possible correlation 
between the maturation processes of both LG compartments (Wang et al. 1995). MECs 
morphological changes are correlated with the increased production of secretory vesicles 
in the acini. At birth and until P7, acinar cells do not exhibit secretory vesicles in their 
cytoplasm and MECs have an immature, round aspect. At P7, few secretory vesicles can be 
observed in the subnuclear region of the acinar cells. At this stage, acini are organized into 
small lobules and MECs, found around the acini, are fl attened and develop short processes 
(Makarenkova and Dartt 2015). At P14, numerous secretory vesicles can be observed in the 
acinar cells cytoplasm. Later on, acini increase in size and MECs develop longer and wider 
processes, forming an arborization embracing the acini. Th e area occupied by MECs in 
comparison to acinar cells decreases with the age of the mouse, and by 4 wo, only 6% of the 
epithelial compartment is occupied by MECs. No signifi cance morphological diff erences 
can be noticed in the LG epithelial compartment between 4 and 8 wo. 
On the molecular level, Farmer and al. recently used single-cell RNA sequencing, 
RT-qPCR and immunohistochemistry staining to highlight the important diff erentiation 
process occurring in all LG compartments between embryonic and postnatal stages 
(Farmer et al. 2017). Th e study revealed the high diversity in LG cell populations, both 
in the epithelial and mesenchymal compartments. Notably, single-cell RNA sequencing 
shows that LG mesenchyme depicts four distinct cell subpopulations at P4, compared to 
only 2 at E16. Moreover, from P0 to 16 wo (adult LG), all LG compartments undergo a 
progressive maturation process. Sox10, Aquaporin5 (Aqp5) and BhlhA15 (also known as 
Mist1) dynamic expressions highlight acinar cell diff erentiation process. Sox10, known 
to be expressed in the LG bud (Chen et al. 2014), is downregulated aft er P7. In contrast, 
Aqp5 and BhlhA15 expressions increase from P1 to P14. Similarly, Lactotransferrin (also 
known as Lactoferrin, Ltf) expression progressively increases in postnatal stages and is 
highly upregulated in the adult LG, as expected from its high concentration in the tear 
fi lm. Furthermore, Krt19 and Slc12a2 (also called Nkcc1), two ductal markers, are mainly 
downregulated in postnatal compared to embryonic LG. Krt5 and Krt14 expression, used 
to study MECs diff erentiation in this study, decrease as well in postnatal stages. 
Th is recent study demonstrates the onset of LG compartments dynamics occurring 
between embryonic and postnatal stages. Taken together, LG epithelial compartment 
diff erentiation is very dynamic. Evidences suggest that the ductal compartment is 
predominant in embryonic LG while the postnatal and adult LGs are mainly formed by the 
acinar compartment.
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1.3.1.3.  LG stem cells and regeneration
Although stem cells (SCs) and progenitors have not been fully characterized in LG, it is 
assumed that such cell populations remain in adult as LG is known to have regenerative 
capacities. Interleukin 1 (IL1)-alpha injections in mouse LG extra-orbital lobe induce an 
infl ammatory reaction resulting in a large acinar cell loss by apoptosis and autophagy 
(Zoukhri et al. 2007; Zoukhri et al. 2008). Th e resulting injury is followed by cell 
proliferation in all LG compartments and further restoration of aqueous tear physiological 
levels. Nonetheless, the time course of LG recovery varies from seven to thirteen days 
depending on the mouse genetic background. 
SCs are involved in organ maintenance and repair. Th erefore, several studies attempted 
to describe LG SCs. MECs are commonly thought to retain SC features. A study on rats 
revealed that MECs express adenosine triphosphate binding cassette superfamily G 
member 2 (ABCG2), along with Musashi 1, Nestin, Pax6, Chx 10, DN p63 and Sox2 (Shatos 
et al. 2012), all known as SC markers (Reynolds and Weiss 1992; Sakakibara et al. 1996; 
Osumi et al. 2008; Fischer and Reh 2000; Hernandez Galindo et al. 2003; Ding et al. 
2010; Violini et al. 2012). Interestingly, a population of cells expressing ABCG2, as well as 
aldehyde dehydrogenase (ALDH, involved in stemness potential) has also been discovered 
in human LG (Tiwari et al. 2012). 
Transcriptomic analysis on regenerating mouse LG revealed an increase in 
muscle related genes, including Sarcalumenin (Srl) and Desmin (Des). However, 
immunohistochemistry staining demonstrated that MECs do not belong to the same cell 
population showing upregulated muscle related genes (Hawley et al. 2017). In addition, this 
study demonstrated Runx1 and Runx3 upregulation (Voronov et al. 2013), both involved in 
SC fate control (Kim et al. 2014; Takacs et al. 2017).
It has been shown in other organs that wound closure, cell extrusion (in case of 
apoptosis for example) as well as cell migration, are well known mechanisms which require 
cell-cell mechano-transduction, cytoskeleton and extracellular matrix (ECM) remodelling 
as well as active cell movements (for review, (Ladoux and Mege 2017)). Th erefore, the 
upregulation of muscle related gene expression in MEC-distinct cells could this way be 
linked to a repair mechanism parallel to stemness and cell proliferation.
LG self-regeneration also involves epithelial-to-mesenchymal transition (EMT). EMT 
leads to the generation of cells with mesenchymal SC-like properties, which migrate to the 
site of injury and initiate LG repair. Subsequently, mesenchymal-to-epithelial transition 
(MET) occurs to generate new acinar and ductal cells (You et al. 2012).
Additionally, the newly formed mesenchymal stem-like cells need to migrate to the 
site of injury, and ECM remodelling is known to play an important role in LG repair 
process. Particularly, numerous ECM modifying enzyme genes (matrix metalloproteinases 
(Mmps), Adams and Adamts), collagens (including Col1a1, Col1a2, Col12a1) and other 
ECM associated factors (including Tgfb 1 and Fn1) are diff erently regulated depending on 
LG regeneration stage (Hawley et al. 2017).
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Up to date, LG SC populations remain to be fully characterized (for review, (Yao and 
Zhang 2017)). Numerous stem/progenitor cell related genes have been studied in LG fi eld, 
aiming at the discovery of one or more LG pluripotent/multipotent cell population(s). 
An epithelial progenitor cell population (EPCP) was recently discovered (Gromova et 
al. 2017). Th is cell population is negative for endothelial, hematopoietic and mesenchymal 
markers. EPCP cells are positive for c-kit protein, the receptor for a cytokine involved in the 
activation of SC proliferation, known as SC factor. In addition, they display an upregulation 
of Oct4 and Vdr (vitamin D receptor) expression, previously reported to be involved in cell 
pluripotency (Blomberg Jensen et al. 2012; Yan et al. 2014). Runx1, reported as a regulator 
of SC survival (Scheitz and Tumbar 2013), was also upregulated. Majority of these epithelial 
progenitor cells are highly proliferative when placed into culture, express Pax6 (reported 
to mark committed transit amplifying progenitors in the corneal epithelium (Kucerova 
et al. 2012; Ouyang et al. 2014)) and can diff erentiate into Aqp5+ secretory cells. Finally, 
these cells are able to engraft  into acinar and ductal compartments when transplanted into 
injured or chronically infl amed LGs and to ameliorate diseased LG physiology.
1.3.1.4.  Pathways involved in LG biology
1.3.1.4.1.  Fgf pathway
Fibroblast growth factor (Fgf) pathway depicts a ubiquitous role both in development and 
disease. Notably, in vertebrate species, Fgf signalling is involved in nearly all tissues, from 
the induction of several organ development in the embryo, to tissue repair in the adult (for 
review, (Ornitz and Itoh 2015)). For instance, Fgf signalling takes part in mammary gland 
and hair follicle formation (Elo et al. 2017; Nguyen et al. 2018).
Fgf pathway is conserved amongst species but the number of proteins in play in the 
signalling cascade varies from one specie to the other. In human and mouse, 22 Fgf ligands, 
four receptors and numerous regulator proteins are known so far (for review, (Ornitz and 
Itoh 2015)). Th e Fgf ligands are diff usible proteins and can be categorized according to 
their function as intracrine, autocrine, endocrine and paracrine. Minority of the ligands 
function either as intracellular ligand (intracrine Fgfs), directly acting in the nucleus, or via 
the circular system in a hormone-like fashion (endocrine Fgfs). Autocrine and paracrine 
Fgfs, also known as canonical Fgfs, represent the majority of Fgf ligands. Th is last category 
of Fgf ligands act either on the same ligand-expressing cell, or on a neighbouring cell. 
Both paracrine and endocrine ligands bind to transmembrane tyrosin kinase Fgf-
receptors (Fgfrs). Heparan sulphate proteoglycans (HSPGs) are regulator proteins and 
function as cofactors to regulate the specifi city and affi  nity of Fgfs. Together, canonical 
Fgf and HSPGs form a ligand complex which bind to the receptor and triggers its 
homodimerization and activation by autophosphorylation. Fgfr activation triggers 
numerous intracellular cascades, including the activation of the Ras/Mitogen-activated 
protein (MAP) kinase pathway (Dorey and Amaya 2010). 
Fgf signalling can be inhibited at diff erent level by established negative feedback loops. 
Fgf inhibitors include Sprouty proteins, as well as XFLRT3 and Sef among others (for 
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review, (Th isse and Th isse 2005; Neben et al. 2017)). For instance, Sprouty-1 and -2 are 
implicated in mammary gland formation (Sigurdsson et al. 2013; Koledova et al. 2016).
In early LG morphogenesis, Fgf7 (also known as Kgf) and Fgf10 are expressed at 
the temporal edge of the eye, in the periocular mesenchyme at E13.5 (Makarenkova et 
al. 2000). FGF7 and FGF10 bind FGFR2. Around E14.5, Fgf7 and Fgf10 are expressed 
in LG mesenchymal compartment, and Fgfr2 in the conjunctival epithelium, where an 
invagination takes place to form LG epithelial bud. Th erefore, Fgf10 was reported as an 
inducer of LG epithelium budding initiation. Lastly, FGF7 and FGF10 loaded beads can 
induce ectopic LG budding in ex vivo cultures. 
1.3.1.4.2.  Bmp pathway
Bone Morphogenetic Protein (Bmp) signalling was originally defi ned for its ability to 
induce ectopic formation of bone or cartilage (for review, (Wozney 1998)). All Bmp 
pathway members, except from the protease BMP-1 (Mac Sweeney et al. 2008), are part of 
the Tgf- super family. Two pathways have been described: the canonical Bmp signalling 
is transduced through two types of serine-threonine kinase Bmp receptors (Bmpr I and 
II) and the non-canonical Bmp pathway signals via the MAPK cascade (for review, (Wang 
et al. 2014)). In addition, Bmp signalling can be inhibited at diff erent levels via antagonist 
proteins which include Noggin, Follistatin and Gremlin among others (Yanagita 2005). 
In the canonical pathway, hetero- or homodimers of ligands bind dimers of receptors I, 
leading to the recruitment of constitutively active type II dimer receptors. Type II receptors 
phosphorylate type I receptors, resulting in fi ne in the phosphorylation of a Smad protein 
complex subsequently translocated to the nucleus. Smad proteins are Bmpr co-factors and 
act as transcription factor. 
Non-canonical Bmp signalling drives the activation of the MAPK pathway via the 
activation of TAK-1, a MAP kinase kinase kinase. Bmp signalling outcomes are broad, as 
the ligands and receptors can associate as homo- or heterodimers, therefore modulating 
and increasing the possible responses. For example, Bmp signalling is involved in lung 
development (Weaver et al. 2000), feather as well as in hair follicle formation (Botchkarev 
and Sharov 2004; Michon et al. 2008).
Numerous Bmp ligands seem to be playing a role in LG biology. BMP4 was reported 
to act as an antagonist to FGF10, negatively regulating LG epithelium expansion. However, 
its action has not been completely unravelled so far (Dean et al. 2004). Bmp7 is expressed 
in both mesenchymal and epithelial compartment during LG development, but mainly acts 
on mesenchymal compartment condensation and proliferation, thus playing an indirect 
role in LG epithelium branching morphogenesis (Dean et al. 2004). BMP7 signalling has 
also been involved in LG regeneration aft er an IL-1 induced injury (Zoukhri et al. 2008). 
Bmp6 overexpression has been observed in LG of dry eye patients, resulting in a decrease 
of lacrimal fl uid secretion (Yin et al. 2013). Last but not least, although the function as not 
been uncovered so far, Bmp3 expression can be found in the LG acinar compartment of P12 
to P18 mice (Th omadakis et al. 1999).
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Together, these studies demonstrate the pleiotropic role of Bmp signalling on LG 
biology. Th ese observations also suggest a possible implication in LG postnatal maturation 
process.
1.3.1.4.3.  Notch pathway
Notch signalling is known to play numerous roles in regulating early organ formation, 
terminal diff erentiation and adult tissue homeostasis. Notch pathway is notably involved 
in cell-fate determination during lens, hair follicle and feather development (for review, 
(Andersson et al. 2011)).
Both Notch ligands and receptors are transmembrane proteins. Th us, Notch signalling 
requires cell-cell contact to be activated. Th is results in the initiation of canonical or 
non-canonical Notch pathways, of which canonical Notch signalling cascade is well 
characterized. In mammal species, four Notch receptors (Notch1-4) and fi ve canonical 
ligands (Delta and Jagged proteins) have been described so far (for review, (Hori et al. 
2013)). However, non-canonical pathways are diverse, involving many regulatory elements 
and downstream proteins which depict context-dependent functions (for review, (Heitzler 
2010)). Th is results in increasingly complex responses. 
Upon cell-cell contact, the ligand binding initiates the proteolytic cleavage of Notch 
receptor in two domains. Briefl y, the complex formed by the ligand and Notch receptor 
extracellular domain (NECD) are endocytosed in the ligand-expressing cell and targeted 
for lysosomal degradation, ensuring a single activation of the receptor. Th e intracellular 
domain of Notch receptor (or NICD) is cleaved by the -secretase. Together with 
downstream proteins, the protein complex formed is translocated to the nucleus where 
it acts as a transcription factor (Hori et al. 2013). Numerous regulator proteins aff ect the 
outcomes of the signalling cascade, for instance by changing the affi  nity of the receptor for 
one or another ligand. Additionally, Notch signalling downregulation is mainly accounted 
for the degradation of NICD into the proteasome (for review,(Kopan and Ilagan 2009)).
Nonetheless, it is important to point out that both receptors and ligands are quite oft en 
expressed by one cell. It is therefore crucial for the cells to establish the signal direction. 
Th is is usually performed by quantitative receptor activation. A current model suggests 
the trans-activation of the receptors in the signal-receiving cell, versus the receptors cis-
inhibition in the signal-sending cell. Th is would result for the cell in a mutually exclusive 
sending versus receiving signalling states, but it has not been tested in vivo (Andersson et 
al. 2011). 
1.3.1.4.4.  Wnt pathway
Wnt signalling plays an important role in ectodermal organs development and is highly 
conserved throughout evolution (Cho et al. 2010). Th e mechanisms of Wnt pathway 
regroup a large amount of proteins, including Wnt ligands, receptors, co-receptors 
and numerous downstream proteins involved in the transmission of Wnt signals. Wnt 
ligands, cell surface  Frizzled (Fz) receptors and low-density lipoprotein receptor-related 
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protein (Lrp) co-receptors act together as a ternary complex to activate one of the three 
intracellular pathways described so far (Bhanot et al. 1996). Lastly, negative feedback loops 
can downregulate Wnt pathway activity. Th is involves the action of Dkk and Axin proteins 
for example (for review,(van Amerongen and Nusse 2009)). 
Th e canonical Wnt pathway, and two noncanonical pathways (Wnt/Ca2+ and Planar 
Cell Polarity (PCP) pathways) have been characterized (Liu and Millar 2010). However, 
it is important to point out that Wnt pathways are regulated at several levels and interact 
with other signalling pathways, resulting in multiple outcomes (van Amerongen and Nusse 
2009). 
Th e canonical Wnt pathway has been extensively studied in mouse ectodermal organs 
(Andl et al. 2002; Chu et al. 2004; Liu et al. 2008; Mikkola 2009). Notably, Wnt pathway 
is active in submandibular gland (major salivary gland, SMG) mesenchyme during 
morphogenesis (Haara et al. 2011). Interestingly, both the inhibition and activation of 
mesenchymal Wnt impairs branching morphogenesis (Patel et al. 2011; Haara et al. 2011), 
refl ecting the need for fi ne-tuned Wnt activity in SMG development. Similarly, the precise 
regulation of Wnt pathway is crucial in other ectodermal organs development, including 
corneal epithelium diff erentiation (Pearton et al. 2004).
Wnt pathway is known to play a role in LG branching (Dean et al. 2005). Indeed, Wnt 
activation (in the epithelium only, or both in epithelium and mesenchyme) leads to LG 
branching inhibition. Reciprocally, the inhibition of Wnt pathway in both compartments 
leads to an increased number of branches.
Interestingly, Wnt and Eda pathways have opposite activation patterns in SMG 
morphogenesis. In this organ, Wnt pathway was previously reported to activate Eda 
pathway during branching morphogenesis (Haara et al. 2011). 
1.3.1.4.5.  Eda/Edar and Troy pathways
Ectodysplasin (Eda) belongs to the tumour necrosis factor (TNF) superfamily and 
is located, both in human and mouse, on the X-chromosome. In human, a complex 
alternative splicing can lead to numerous transcripts, but only Eda-A1 and Eda-A2 were 
so far reported as biologically signifi cant (Bayes et al. 1998a; Mikkola et al. 1999). Human 
and mouse Eda-A1 and Eda-A2 are highly homologous. Although, in both species, only 
two amino acids diff er from both Eda variants, the diff erence in both proteins accounts 
for their affi  nity to diff erent receptors. EDA-A1 binds EDAR, encoded by Edar which 
was reported to be expressed during LG initiation (Pispa et al. 2003). EDA-A1 pathway 
is involved in numerous ectodermal organ development, including tooth and salivary 
gland morphogenesis (Pispa et al. 1999; Jaskoll et al. 2003). In the latter, Eda signalling 
is restricted to the epithelial compartment and is necessary for branching morphogenesis 
(Haara et al. 2011). EDA-A2, specifi c for EDA2R (also known as XEDAR), has not been 
reported to be involved in ectodermal organogenesis. Th erefore, EDA-A1 is commonly 
referred as Eda ligand.
Eda signalling acts principally in a paracrine manner. Eda pathway elements are 
mainly composed of the Eda transmembrane ligand, its receptor Edar, and Edaradd, an 
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Figure 8: Eda pathway. Soluble EDA-A1 binds EDAR. Together, the ligand and receptor 
transmit the signal via an adapter molecule EDARADD. Th e EDA/EDAR/EDARADD complex 
activates the intracellular signalling cascade through TRAF6/TAB2 and TAK1 proteins, which 
further recruit IB kinase complex (IKK). IKK complex phosphorylates IB, which is directed 
to the proteasome aft er polyubiquitination. Th is last event leads to the degradation of IB, 
releasing an active NF-B. Consequently, NF-B gets translocated to the nucleus where it acts 
as a transcription factor. In case of Eda-A1 mutation, the signalling cascade is not initiated. 
Th is leads to X-linked hypohidrotic ectodermal dysplasia (XLHED) in human, which is 
characterized by several ectodermal defi ciencies, including missing or abnormally formed teeth, 
and bone defects. Pictures from (de Aquino et al. 2012).
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adaptor molecule, binding the receptor on its death domain in the intracellular portion. 
Upon activation, the extracellular domain of Eda ligand is cleaved and becomes soluble. Th e 
soluble Eda fragment binds Edar receptor on the signal-receiving cell. Eda/Edar/Edaradd 
complex activates an intracellular signalling cascade. Th e downstream pathway leads to the 
phosphorylation and ubiquitination of IκB, which is directed for proteasomal degradation. 
In fi ne, this results in the release of NF-κB and its translocation into the nucleus, where it 
acts as a transcription factor (fi gure 8). It was also reported that Edar signalling can weakly 
activate the c-Jun N-terminal kinase (Jnk) pathway, not described here (Kumar et al. 2001).
NF-κB signalling is active in numerous ectodermal organs, including those that are not 
severely aff ected by Eda, Edar or Edaradd loss-of-function mutations (Bhakar et al. 2002; 
Dickson et al. 2004). Th erefore, another pathway was thought to be redundant to this one.
Edar receptor was previously established as the closest counterpart of Troy, another 
TNF receptor. In contrast to Edar, Troy does not contain a death domain, representing 
the binding site for Edaradd. For this reason, TROY is thought to be closer to EDA2R, 
and to activate the downstream cascade leading to NF-B activation independently to 
Edaradd recruitment. Troy pathway was reported to act redundantly to Eda/Edar signalling 
in hair follicle formation (Pispa et al. 2008). However, Troy possible ligands remain to be 
elucidated.
1.3.1.4.6.  Integrated regulatory network
Gene regulatory networks (GRNs) are constituted of numerous regulator substances leading 
to a precise control of gene expression, both spatially and temporally. GRNs regulation 
results in fi ne-tuned developmental processes (for review, (Levine and Tjian 2003)). Fgf10, 
Bmp7 and canonical Wnt signalling interact during LG morphogenesis. Th e integration 
of these signalling pathways is necessary for LG epithelial bud outgrowth and further 
controlled branching formation (Dean et al. 2005). Th erefore, it is crucial to consider all 
the molecules included in the highly integrated regulatory networks, organ-specifi c and 
context-dependent during development.
1.3.2. LG physiology
1.3.2.1. Basal, refl ex and psycho-emotional tear secretion
Th ree types of tears can be distinguished in human: basal, refl ex and psycho-emotional 
tears. Main and accessory LGs are the main modulators of the diff erent type of tear 
secretion (for review, (Tsubota 1998; Murube 2009)). Nonetheless, the diff erent types of 
tears are variable in composition. 
Basal tears represent the only type of tears already secreted during the foetal life 
(Murube 2009), before corneal and LG maturations are completed. Refl ex tears production 
begins shortly aft er birth. Refl ex tears participate to the return to homeostasis aft er corneal 
nociceptive stimuli which include corneal wounds, foreign bodies and infl ammation. 
Th erefore, refl ex tears contain variable proteins helping to restore the basal tearing state 
(Tsubota 1998). Finally, psycho-emotional tears secretion starts the latest, some months 
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aft er birth. Th is type of tears is specifi c to human and is up to date thought to have rather a 
social purpose than a biological impact on the corneal environment (Murube 2009).
1.3.2.2. LG innervation 
Adequate responses to environmental factors include pathogens elimination via tear 
fi lm factor secretion. Although both parasympathetic and sympathetic nervous systems 
innervate the LG, parasympathetic signals are predominant and present in all species (for 
review,(Dartt 2009)). As a matter of fact, parasympathetic denervation leads to 70% tear 
production decrease, along with an accumulation of secretory vesicle in rabbit (Toshida 
et al. 2007). Up to date, the role of LG sympathetic innervation remains under discussion. 
Eff erent nerve activation leads the release of neurotransmitters directed to LG 
acinar compartment. Acetylcholine and Vasoactive intestinal peptide (VIP) are released 
by the parasympathetic nerves, norepinephrine by the sympathetic ones. Th ese three 
neurotransmitters activate acinar secretion, resulting in the production and exocytosis 
of proteins, electrolytes and water in the acinar lumen. Neurotransmitters are integrated 
at the basolateral side of the acinar cells, protein exocytosis happens at the apical side, 


















Figure 9: Innervation leading to tear secretion. Upon stimulus, aff erent sensory nerves from 
the cornea and the conjunctiva get stimulated. Th ey project in the central nervous system and 
activate parasympathetic and sympathetic responses. Eff erent parasympathetic and sympathetic 
nerves stimulate the diff erent lacrimal gland (LG) compartments to induce fl uid secretion. Th is 
forms a nervous circuit connecting the LG and the ocular surface. Modifi ed from (Zoukhri 
2006; Dartt 2009).
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towards the lumen (fi gure 9). In contrast, the parasympathetic system has been suggested 
to secrete enkephalin (Lehtosalo et al. 1989), and the sympathetic to secrete neuropeptide 
Y (Matsumoto et al. 1992), both thought to have negative eff ect on lacrimal fl uid secretion. 
However, so far, very little is known about these opposite eff ects (for review, (Hodges and 
Dartt 2003)).
Neural stimulation is graded by combination of corneal sensory inputs and emotional 
inputs, which together determine the amount tears to be produced. A low nerve stimulation 
will result in the production of basal tear fl ow, necessary amount to cover the eye surface. 
A higher input will generate an increased lacrimal fl ow to wash away a foreign body for 
example.
1.3.2.3.  LG hormonal stimulation
Numerous studies reported gender diff erences in LG morphology and function (for review, 
(Warren 1994)). Moreover, dry eye diseases (DEDs), resulting from a defi ciency in the 
lacrimal functional unit, have a higher prevalence in females. Moreover, DED incidence 
in female increases aft er menopause. Th ese evidences triggered the study of sex hormone 
infl uence on LG functions. It is now acknowledged that hormones, including the sex 
hormones androgens, progesterone and oestrogens, play a role in the modulation of LG 
secretive functions. Higher levels of androgens have been associated with higher LG fl uid 
secretion and heavier weight in males. In contrast, changes in oestrogen levels in female 
have been indirectly associated with lower LG function through androgen availability 
reduction (Johnson and Murphy 2004).
1.3.2.4.  LG ageing
Ageing is associated with a decrease in refl ex tear volume. Th ese tears are mainly secreted 
by the LG, which encounters age-related structural and functional changes (for review, 
(Rocha et al. 2008)). In mouse, the fi rst signs of ageing represent a decline in both 
innervation density and parasympathetic nerve activity occurring around 8 months of age. 
Th e decrease in acini innervation seems to be followed by immune cell infi ltration and 
structural changes, including general fi brosis and interlobular ductal dilatation (Rios et al. 
2005). In addition, LG acinar mass has been reported to decline from 12 months of age in 
mice (Rios et al. 2005). Except from the innervation density decrease, similar structural 
changes were also reported in human (Obata et al. 1995). Nonetheless, corneal sensitivity 
decrease was highlighted in human. Together, these structural changes were suggested 
to aff ect the secretory response (both tear quality and quantity) observed in elderly mice 
(from 24 months of age onwards) and human (Rocha et al. 2008). Moreover, in rodents, 
the type of acini tends to switch with age from serous to mucous (Draper et al. 1999). Up to 
date, this last characteristic has not been reported in human.
Th e eff ects of ageing on LG function depict inconsistencies amongst the diff erent 
studies. On a molecular level, only the total protein secretion is consistently reduced during 
aging in rodent (Rocha et al. 2008).
Review of the literature
21
1.4.  Lacrimal func  onal unit defi ciency and therapeu  c strategies
1.4.1.  Tear film and lacrimal gland function
Tears carry a large amount of proteins, of which the main representatives are portrayed by 
four proteins. LTF and lysozyme, two proteases, have antibacterial and antiviral functions; 
lipocalin and secretory type A immunoglobulins (Eiraku et al. 1998) are involved in the 
activation of the immune system response on the eye surface. LG acinar cells primarily 
release LTF, lysozyme and lipocalin via fusion of secretory vesicles in the lumen. IgAs are 
however produced by interstitial plasma cells. Th ese four factors represent up to 80% of the 
fi nely regulated tear fi lm proteome (Walcott 1998; Hodges and Dartt 2003).
Moreover, LG is secreting all growth factors necessary for corneal maturation and 
homeostasis maintenance, as the cornea is an avascular organ. Growth factors are involved 
in cell survival, proliferation, diff erentiation and migration and the outcomes are oft en 
dose-dependent (for review, (Klenkler et al. 2007)). Growth factor secretion is variable upon 
numerous factors which aff ect both the quality and the quantity of LG fl uid composition. 
For this reason, it is diffi  cult to determine the precise concentration of each specifi c growth 
factor in the tear fi lm. LG-secreted growth factors include transforming growth factor-
beta (TGFb), hepatocyte growth factor (HGF) and epidermal growth factor (EGF), among 
others. TGFb and HGF play pleiotropic roles in corneal epithelium homeostasis (Klenkler 
et al. 2007). EGF notably acts as a paracrine factor by increasing CE proliferation as well as 
an autocrine factor by enhancing LG protein secretion (Xiao et al. 2012).
1.4.2.  Cornea wound healing
Corneal abrasion is one of the most common clinically found eye injuries which, in human, 
heals spontaneously. Cornea repair follows several steps that are well conserved. Aft er 
feline corneal insult, an early CE cell migration occurs as early as 8 hrs post abrasion. Late 
migration continues until the wound closure, around 2 days post injury, and is followed 
by CE stratifi cation from day 3 to day 6 post injury. At day 7 post wound, the CE is back 
to its original state (Petznick et al. 2013). LG secretion supports the CE repair process. 
Upon cornea wounding, LG specifi c production is increased in response to the injury (for 
review,(Klenkler et al. 2007)). Th is leads to the upregulation of growth factors in LG fl uid. 
Th ese factors initiate the corneal healing process. Although the molecular events occurring 
during CE regeneration are not yet fully unravelled, it is established that LG growth factors 
production is diff erently regulated in response to cornea wounding (Tervo et al. 1997; 
Wilson et al. 1999). For instance, it is known that EGF concentration is highly increased 
immediately aft er the wound but returns to a more basal concentration rapidly aft er corneal 
healing initiation (Sheardown and Cheng 1996). 
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1.4.3.  Dry eye diseases
1.4.3.1.  Overview
Irregularities in the pre-ocular tear fi lm quality results in the deterioration of the CE and dry 
eye. Dry eye diseases (DEDs) are also known as keratoconjunctivitis sicca (KCS) or keratitis 
sicca. Although the percentage varies tremendously, in the nineties, the prevalence of DEDs 
could be estimated between 11-22% of the general population (for review, (Abelson et al. 
2009) (Brewitt and Sistani 2001)). Since environmental factors infl uence DEDs prevalence 
(Alves et al. 2014), it is to be expected that this number will increase further due to climate 
changes and pollution aff ecting the quality of the air (for review, (Kinney 2008)). Moreover, 
the ageing of the population raises DEDs incidence: more than 35% of the elderly suff er 
from DED (Gayton 2009) and up to date, no curative treatment is available.
DEDs can be categorized into either evaporative or aqueous defi cient DEDs, resulting 
from multifactorial causes (for review, (Bron 1997) and (Craig et al. 2017)) (fi gure 10). 
Aqueous defi cient-DEDs originate from LG defi ciencies and are usually categorized as 
Sjögren’s syndrome (SjS) and non-SjS types (for review, (O’Brien and Collum 2004)). In case 
of aqueous defi cient-DED, LG aqueous component secretion mainly is reduced which leads 
to a shortage in tear fi lm (Messmer 2015). Th ese types of DEDs can result from numerous 
phenomena impacting LG function, including, in a non-exclusive manner, reduced neural 
or hormonal stimulation, ductal occlusion or acinar cells loss. 
MG defi ciencies and eyelid aff ections lead to evaporative-DEDs. In this case, the tear 
fi lm has a decreased evaporation time, resulting from lipid composition variation (both 
in quality and quantity) as well as in the reduced thickness of the tear fi lm lipid layer (for 
review, (Zhang et al. 2017)). Moreover, in case of evaporative dry eye, LGs try to compensate 
by increasing their production. Th is commonly results in waterier eyes. 
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Nevertheless, these categories simplify the reality, as both types of dry eye oft en coexist 
(Johnson and Murphy 2004; Craig et al. 2017).
1.4.3.2.  X-linked Hypohidrotic Ectodermal Dysplasia
As detailed above, Eda pathway plays a role in the formation of several ectodermal organs. 
In mammals, Eda loss-of-function leads to X-linked hypohidrotic ectodermal dysplasia 
(XLHED, OMIM 305100) (Srivastava et al. 1997; Bayes et al. 1998b; Headon et al. 2001; 
Kowalczyk et al. 2011), characterized by severe symptoms. Th ese include dry eye, xerostomia 
and body temperature misregulation, respectively linked to lacrimal, salivary and sweat 
gland hypoplasia (Dietz et al. 2013; Jones et al. 2013). In addition, XLHED patients depict 
severely aff ected MGs (Tyagi et al. 2011), contributing to the dry eye phenotype.
Th e tabby mouse model depicts a spontaneous Eda loss-of-function mutation 
(Eda-/-, tabby). Eda-/- mutants share similar symptoms with XLHED human patients and 
are therefore commonly used as XLHED models (Srivastava et al. 1997; Cui et al. 2005). 
Up to date, Eda-/- mutants dry eye phenotype was solely attributed to their atrophied or 
completely missing MGs, characterizing it as an evaporative dry eye model (Wang et al. 
2016). Although Eda-/- mutants depict atrophied LGs in mouse embryos (Grüneberg 1971), 
Eda pathway implication in LG biology has been disregarded so far.
1.4.3.3.  Other types of dry eye
As mentioned above, DEDs oft en combine evaporative and aqueous defi ciency, and the 
following examples only highlight the multifactorial characteristics of these aff ections.
A transgenic mouse model with mitochondria-induced oxidative damage in the LG 
has been developed to study aged-related aqueous-defi cient DED (Uchino et al. 2012). 
Although ageing is one of the most common condition leading to dry eye, numerous other 
causes can also lead to symptomatic dry eye (both aqueous-defi cient and evaporative) 
(Javadi and Feizi 2011). 
Th ese include genetic disorders (above mentioned XLHED), autoimmune diseases 
(SjS, see below), medication intake (Acan and Kurtgoz 2017) or contact lenses wear (Lubis 
and Gultom 2018) and specifi c physiological status such as pregnancy (Ding et al. 2011), 
eye surgery (Levitt et al. 2015) or diabetes (Imam et al. 2013). 
Notably, SjS is an autoimmune aff ection leading to lacrimal and salivary glands chronic 
infl ammation. SjS results in DED and xerostomia. Particularly, LGs from SjS patients 
present an immune cells infi ltration and high acinar cell death by apoptosis (Tabbara and 
Sharara 1999). Numerous mouse models depict SjS-like diseases, including NOD and 
MRL/lpr mice (for review, (Jabs and Prendergast 1994; Lee et al. 2009)). 
LG neural and hormonal stimulations play a crucial role in LG secretion. For instance, 
pituitary adenylate cyclase-activating polypeptide (PACAP)-null transgenic mice display 
dry eye symptoms and PACAP is known to act both as hormone and neurotransmitter 
(similar to VIP, specifi c of the parasympathetic nervous system) (Nakamachi et al. 2016). 
Physical trauma, such as bone fractures, can lead to the disruption of parasympathetic 
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innervation and LG defi ciency. Th is represent the most common cause of DED in horses 
(Ollivier 2004). A more drastic aqueous defi cient dry eye model consists in the complete 
excision of the extra-orbital LG lobe in mouse (Shinomiya et al. 2018).
Finally, environmental factors such as air humidity is also a risk factor for dry eye. A 
controlled-environment chamber has been developed to study the eff ect of dry air on eye 
surface allowing imposed variations to the environmental factors (Barabino et al. 2005). 
1.4.4.  Therapeutic strategies
Various therapeutic strategies are employed to target dry eye aetiology, derived symptoms 
and to mostly bring palliative relief (for review, (Zhang et al. 2017)). Amongst them, 
artifi cial tears or tear substitutes; bioengineered LGs and SC injections, as well as artifi cial 
plugs can be used to address LG defi ciency. 
1.4.4.1.  Tear substitutes
A lot of research eff orts are directed towards the establishment of various lacrimostimulants, 
stimulating tear production, and lacrimomimetics, replacing all or parts of the tear fi lm, to 
treat dry eye conditions (for review, (Grahn and Storey 2004)). However, artifi cial tears are 
up to date the most common treatment used to alleviate dry eye symptoms. Other type of 
tear substitutes are also investigated. Notably, autologous serum has a composition close 
to the tear one, and the benefi cial eff ect of autologous serum drops has been reported 
to improve eye health in human studies (for review, (Kojima et al. 2008)). However, 
acquisition and conservation of the serum is a major issue (Lee and Chen 2008), and the 
effi  cacy of the autologous serum-based treatments are variable from one clinical trial to the 
other (Pan et al. 2013). Similarly, the use of Albumin to supplement artifi cial tears refl ect 
an improvement of the symptoms in patients suff ering from SjS-derived aqueous defi ciency 
(Shimmura et al. 2003).
Whether these tear substitutes are only mimicking the basal salinity of the endogenous 
tears, or whether it is supplemented with other components, the technique is nowadays 
only destined to ease the discomfort, leaving the source of the problem unresolved.
1.4.4.2.  LG bioengineering
Th e transplantation of entire organs as a therapeutic strategy to replace a defi cient organ 
is a method in use for numerous organs nowadays. However, organ availability and the 
possibility of allogenic immunological rejection bring important issues. Th erefore, organ 
bioengineering was developed to overcome these and create functional organs to replace 
dysfunctional ones. Th ese new regenerative methods take advantage from organ-specifi c 
SC and use an in vitro three-dimensional setup to reconstruct entire organs (for review, 
(Hirayama et al. 2013b)).
Similarly to tooth and hair follicle, bioengineered LG was developed from a previously 
reported organ germ method (Hirayama et al. 2017). Following, endogenous LG removal, 
the transplantation of a bioengineered LG showed similar physiological function in 
engraft ed mice compared to controls (Hirayama et al. 2013a; Hirayama et al. 2015). 
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Th is included tear volume, major protein secretion (including lactoferrin) and neural 
stimulation.
Consequently, some studies reported the successful development of human LG 
spheres, or “lacrispheres” as a promising therapeutic strategy to be further investigated (for 
review, (Tiwari et al. 2014) and (Tiwari et al. 2012)). 
1.4.4.3.  Other approaches
In some clinical cases, autologous submandibular gland transfer was reported to be an 
option (Yao and Zhang 2017). Although the outcomes seem very positive and DED 
symptoms are reduced, this operation is not a possibility for patients suff ering from 
autoimmune diseases or any physiological condition leading to xerostomia (Yu et al. 2004) 
(Macleod et al. 1990).
Mesenchymal SCs have demonstrated interesting tissue repair functions in the case 
of LG function defi ciency derived from specifi c autoimmune diseases (such as SjS) (for 
review, (Lu et al. 2017)). Mesenchymal SCs can be isolated and cultured from LG (You 
et al. 2011). Th e injection of mesenchymal SCs thus represents one promising therapeutic 
approach to treat the source leading to DEDs, rather than the symptoms.
Finally, lacrimal puncta or canalicular plugs have been used to reduce the loss of tears 
by occluding the lacrimal drainage system (for review, (Tost and Geerling 2008) and (Ervin 
et al. 2017)). Artifi cial plugs represent a possible treatment in case of severe dry eye, helping 
to preserve the natural tears by temporary or permanent blockage. In the most extreme 
situations, surgical closure of the puncta can be an option. 
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2. AIMS OF THE STUDY
LGs represent a crucial element in the production of the eye-protecting tear fi lm. Numerous 
aff ections can impair LG function, especially the tear quality and quantity. Lower tear 
fi lm quality results in reduced eye vision. To develop therapeutic strategies aiming at 
restoring proper eyesight in human, a general knowledge improvement on the mechanisms 
governing LG biology is required. I used several mouse models to generate new information 
participating in the understanding of the physiology of the eye anterior segment.
My research work focused on the understanding of LG development, maturation and 
function.
Th e main aims of my thesis were:
1. To elucidate the principal cellular events occurring during LG early formation,
2. To investigate the molecular mechanisms promoting cell diff erentiation and their 
implication in early LG development,
3. To unravel the role of Eda signalling in LG morphogenesis, maturation and 
function,
4. To study the crosstalk occurring between LG and cornea during cornea wound 
healing, both in healthy and dry eye conditions.
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3.  MATERIALS AND METHODS
3.1.  Mouse lines 
Th e mouse lines used were previously described. Table 1 recapitulates the diff erent 
mouse strains involved in each study, along with the original publication describing the 
corresponding transgenic line and its genotyping. 
Wild-type ICR mice were used in study I and II, C57BL/6 mice in study III. 
In the study I, SMA-cre (LeBleu et al. 2013) and Krt14-cre43 (Andl et al. 2004) 
were crossed with R26R-Confetti (Snippert et al. 2010), R26R-TdTomato (Madisen et al. 
2010) and R26R-mT/mG (Muzumdar et al. 2007) reporter lines to follow the cell progeny 
of SMA+ and Krt14+ cells respectively. In the study III, all mice were kept in C57BL/6 
genetic background to avoid LG development timeline diff erence. In this study, Krt14-
Eda (Mustonen et al. 2003) and Krt14-Edar (Pispa et al. 2004) were crossed with NF-B-
gal (Bhakar et al. 2002) reporter line to follow Eda pathway activity in gain-of-function 
conditions. 
Th e mice were used at diff erent embryonic, postnatal and adult stages. Plug date was 
considered as embryonic day (E)0, and birth date as postnatal day (P)0. 
Table 1.  Mouse lines used in the doctoral thesis project
Mouse strain Used in Reference
SMA-cre I LeBleu et al., 2013
C57BL/6 III
Eda-/- (tabby) III Falconer, 1952; Srivastava et al., 1997
Fucci I Sakaue-Sawano et al., 2008
ICR I; II
Krt14-cre43 I Andl et al., 2004
Krt14-Eda III Mustonen et al., 2003
Krt14-Edar III Pispa et al., 2004
NF-B-gal III Bhakar et al., 2002
R26R-Confetti I Snippert et al., 2010
R26R-TdTomato I Madisen et al., 2010
R26R-mT/mG I Muzumdar et al., 2007
All aspects of the mouse experiments performed in this thesis followed the approval by the 




All methods used are described in detail in the original publications (Kuony and Michon 
2017; Kalha et al. 2018a) and in the manuscript of the study III. Th e following techniques 
were used during the accomplishment of the doctoral dissertation project:
3.2.1.  Gene expression profiling
 RNA extraction, cDNA synthesis, RT-PCR and RT-qPCR analyses (studies I and III)
RNeasy microkit and QuantiTect Reverse Transcription Kit (Qiagen) were used respectively 
to extract total RNA from snap-frozen tissues samples and generate the corresponding 
cDNAs. 
Following cDNA synthesis, RT-PCR or multiplex RT-qPCRs were performed to 
analyse specifi c gene expression profi les. Th e advantages off ered with multiplex RT-qPCR 
include the possibility to analyse 4 genes simultaneously (3 genes of interest + one house 
keeping gene).
 Microarray analysis (study I) and RNA sequencing (study III) 
Microarray analysis and RNA sequencing were performed by the Functional Genomics 
Unit (FuGU, University of Helsinki), for genetic expression profi ling. 
Th e transcriptome of embryonic (E18) and adult (34 wo) LGs (epithelial and 
mesenchymal compartments) were compared by microarray in the study I. E18 was chosen 
due to the relative stability of the branching state between individuals at this stage. Th e 
microarray results are available on the Genome Expression Omnibus (Michon et al.) 
platform under the GEO accession number GSE103743. For the microarray analysis, we 
used a cut-off  value of P < 0.05, and studied the diff erently expressed transcripts presenting 
a fold change whether below -2, or above 2.
Gene expression diff erences between 13 wo-Eda-/- and -control LGs (epithelial and 
mesenchymal compartments) were analysed by RNA sequencing in the study III. Th e RNA 
sequencing results will be available on the Genome Expression Omnibus (Michon et al.) 
platform upon acceptance of the manuscript. For the RNA sequencing analysis, we used a 
cut-off  value of P < 0.05, and studied the diff erently expressed transcripts presenting a fold 
change whether below 0.7 or above 1.3.
 RNAscope technology for in situ hybridization (study III)
Single molecules of target mRNA were detected on paraffi  n sections using RNAscope 2.5 
HD Duplex chromogenic kit (Advanced Cell Diagnostics) according to previously reported 
protocols (Wang et al. 2012).
3.2.2.  Tissue processing (studies I-III)
Tissues were fi xed at 4C with 4% PFA in PBS, except from NF-B-gal samples (study III) 
which were fi xed with 2% PFA complemented with 0.2% glutaraldehyde in PBS. For whole-
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mount staining (studies I and III), dissected LG samples were dehydrated and kept in 70% 
EtOH at 4C until further use. For histology, immunofl uorescence on slide, RNAscope and 
X-gal staining, samples were embedded in paraffi  n and cut at 5 μm thickness.
Embryonic stages E17 and E18 were decalcifi ed using EDTA for up to 2 weeks at 4C 
prior embedding.
3.2.3.  Histology and Immunohistochemistry
 Histology (studies I-III)
Haematoxylin-Eosin and nuclear fast red staining were used to counterstain cell nuclei 
(Haematoxylin and nuclear fast red) and cytoplasm (Eosin) in tissue sections, following 
well established routine protocols. 
 Immunofl uorescence staining on sections (studies I and II)
An antigen retrieval machine (Aptum Biologics Ltd) was used to unmask epitopes. Primary 
and secondary antibodies used, and their concentration are described in another section.
 Whole-mount Immunofl uorescence staining (studies I and II)
Th e antibodies used, and their concentration are described in the section 3.3.
3.2.4.  Eda pathway activity assessment (study III)
NF-B promoter-driven  -galactosidase (gal) expression was detected with an X-gal 
staining solution. Aft er pre-fi xation and washing, the samples were incubated overnight 
at room temperature of +37C in an X-gal staining solution. Following washing and post-
fi xation, the samples were further processed for paraffi  n embedding, sectioning and 
counterstaining.
3.2.5.  Ex vivo cultures (study I)
Embryonic LGs were cultured in an ex vivo setup for up to 4 days, at the interface liquid-air, 
following a protocol previously described (Munne et al. 2013). Dissected LGs (epithelial and 
mesenchymal compartments) were cultured on nucleopore fi lter membrane (Whatman), 
on a metal grid in tissue culture petri dishes containing culture medium. Ex vivo cultures 
were maintained in a control atmosphere (5% CO2, +37C). 
 Notch pathway inhibition
Notch pathway was inhibited by adding 10 μM DAPT (-secretase inhibitor) to the culture 
medium. Medium was changed every day, away from light. Although DAPT is known to 
have an eff ect on off -targets (Zhao et al. 2008; Yoo et al. 2012), it is commonly used to 
inhibit Notch pathway by impairing NICD cleavage (Jiang et al. 2011; Dvoriantchikova et 
al. 2017; Jing et al. 2017).
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3.2.6.  In vivo experiments
 Cornea wounding (studies II and III)
Central corneal epithelial surface was injured using an ocular burr (Alger company), 
following the published protocol (study II) (Kalha et al. 2018a). Th e wound borders and 
further closure were followed with 0.1% fl uorescein staining.
 Blinking rate measurement and tear collection (study III) 
Blinking rate and tear volume measurement were used to assess the level of ocular 
dryness in adult mice. Tear collection was performed using 0.5 μl glass micro-capillaries 
(Drummond Scientifi c).
3.2.7.  Imaging, data analysis and statistics (studies I-III)
 Imaging
Ex vivo cultures images were acquired with a Zeiss Lumar stereomicroscope. Fixed samples 
containing fl uorescence staining were imaged using Leica TCS SP5 and SP8 confocal 
microscopes. Haematoxylin-Eosin, Haematoxylin counterstained RNAscope and nuclear 
fast red counterstained X-gal staining were imaged using a Leica DM6000 microscope. 
Whole-mount X-gal staining samples were imaged using an Olympus SZX9 binocular 
microscope. 
 Data analysis
Images were analysed using Imaris 8.4.1 (Bitplane) soft ware and processed with Photoshop 
CC (Adobe Systems). All panels were made on Illustrator CC (Adobe Systems).
 Statistics
Standard deviation and student t-tests (unpaired, two-tailed) were used to determine the 
statistical signifi cance of the results.
3.3. An  bodies (studies I and III)
Table 2 describes the primary antibodies used in this thesis. Th e secondary antibodies 
used included anti-mouse AlexaFluor 568 and anti-rabbit AlexaFluor 488 (1/500, Life 
Technologies). All samples were counterstained with Hoechst 33342 (1/2000, Life 
Technologies) prior mounting in Vectashield (Vector Laboratories).
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Table 2. Primary antibodies used in the doctoral thesis project




Anti-SMA mouse Abcam, ab7817 1/100 1/100
Anti-SMA rabbit Abcam, ab5694 1/100 1/100
Anti-Casp3 rabbit Cell Signalling, 9661S 1/400 -
Anti-ECAD mouse BD Biosciences, 610182 1/500 1/750
Anti-ECAD rat Th ermoFisher, 13-1900 - 1/750
Anti-Krt14 rabbit Th ermo Fisher Scientifi c, 
RB-9020-P
1/100 1/100
Anti-Krt14 mouse Abcam, ab780 1/100 1/100
Anti-Krt19 rabbit Abcam, ab52625 1/100 1/100
Anti-Notch2 rabbit Abcam, ab8926 1/100 1/100
Anti-Notch2 rabbit ImmunoWay, YC0069 1/100 -
Anti-
phospho-H3
rabbit Abcam, ab5176 1/100 -
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4.  RESULTS AND DISCUSSION
4.1.  Epithelial cell popula  ons diversity in embryonic and postna-
tal LG (study I)
4.1.1.  Overview
Little was known about the genetically encoded program involved in the specifi c cell 
diff erentiation leading to LG patterning. I performed a microarray analysis to compare the 
transcriptomic signature of developing (E18) and fully mature (34wo) LGs. As expected, 
the microarray results highlighted that genes commonly found in mature LG (Farmer et al. 
2017) were enriched in the adult sample. In contrast, the analysis revealed numerous genes 
enriched in embryonic LG, uncovering specifi c epithelial markers not reported previously 
during LG embryonic development. Th is showed LG postnatal maturation and brought 
new leads to characterize LG epithelium territory formation.  
4.1.2.  Acinar compartment and MECs
Keratin 14
Hirayama et al. reported an increased expression of Krt14 and Krt5 in 7 wo LGs (Barabino 
et al. 2005). In addition, Krt14 and Krt5 expression have recently been proposed to mark 
a unipotent SC population in adult LG epithelium (Farmer et al. 2017)a. LG encounters 
a gradual maturation from 8 wo to 16 wo (Farmer et al. 2017). Reciprocally, I found that 
Krt14 expression is higher in 34 wo adult LG compared to embryonic LG. Using RT-qPCR, 
I showed a constant increase of Krt14 expression levels from E15 to 34 wo (see study I, 
fi gure S1A). 
I used immunohistochemistry staining to determine KRT14 location in developing 
and mature LG. I found that KRT14 is localized in LG epithelium, from the early LG germ 
onwards. Specifi cally, KRT14 gets restricted to the basal cell layer with the beginning of 
branching morphogenesis in the embryo (see study I, fi gure 2). In adult LG, KRT14 is 
found in MECs and in the basal layer of the ducts. Although KRT14 is broadly found in 
embryonic stages, acinar cells are KRT14 negative in adult LG (see study I, fi gure S3A).
Alpha smooth muscle actin (Acta2, encoding for αSMA)
SMA is a well-established marker for MECs (Makarenkova and Dartt 2015). I 
demonstrated that Acta2 is expressed at all stages in the LG, its expression continuously 
increasing from E15 to 34 wo (see study I, fi gure S1A). While Acta2 was previously 
reported in LG (Makarenkova and Dartt 2015), Acta2 embryonic expression pattern had 
not been established before. I showed that SMA is scattered in LG epithelial germ and 
gets gradually restricted to the basal cell layer in the TEBs (see study I, fi gure 3A and B). 
Although Acta2+ cells are less abundant than Krt14+ cells in embryonic LG, whole-mount 
and section immunohistochemistry staining demonstrated that SMA partially colocalizes 
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with KRT14 during LG development (see study I, fi gure 3C). In adult LG, SMA remains 
in MECs (Makarenkova and Dartt 2015). In addition, SMA also marks the basal layer of 
suspected blood vessels, as Acta2 is known to be expressed in vascular smooth muscle cells 
(Granata et al. 2015) (see study I, fi gure S3A).
My results showed that Krt14 and Acta2 defi ne three specifi c cell populations, i.e. 
Krt14+ and Acta2+ single positive, and Krt14+;Acta2+ double positive cell populations.
Aquaporins
Aquaporins (AQPs) can be separated into three categories: conventional and unorthodox 
AQPs, and aquaglyceroporins (Schey et al. 2014). Interestingly, my transcriptomic analysis 
only depicted a signifi cant expression of conventional and unorthodox AQPs in the LG. 
Particularly, while Aqp1 transcripts were enriched in embryonic LG (18 fold), Aqp5 and 
Aqp8 were more expressed in the adult (13 and 132 fold respectively). Although AQP5 
is known to be localized in the acini (Schey et al. 2014), AQP1 and AQP8 localizations 
are unclear in the LG. It was previously suggested that AQP1 is at least found in LG 
microvascular endothelia, but no precise expression pattern has been established so far 
(Hamann et al. 1998). Aqp5 expression can be used as a marker of mature secretory system 
in the acini (Ishida et al. 1997). However, I showed by RT-PCR that while Aqp1 was only 
expressed until P21, Aqp5 was expressed at any embryonic and postnatal stages. Finally, 
I found that Aqp8 expression was restricted to postnatal stages (see study I, fi gure S3B). 
Th erefore, I suggest that studying these three AQPs together might give a better overview of 
the progressive secretory program acquisition in LG. Indeed, as the eyelid opening happens 
between P12 and P14 in the mouse, it is possible that the AQPs profi le changes to adapt to 
the cornea needs.
4.1.3. Ductal compartment
Keratin 19 and 17
KRT19 staining was previously used to mark salivary gland ducts (Nedvetsky et al. 2014). 
My microarray results depicted a Krt19 enrichment in embryonic LG (18 fold). Using 
RT-qPCR, I confi rmed that Krt19 expression was higher in E18 rather than in 34 wo LG. 
Moreover, studying Krt19 expression during embryonic LG formation revealed a constant 
increase from E15 to E18 (see study I, fi gure S1B). 
To go further, I studied KRT19 location by immunohistochemistry staining and 
established it as a marker for LG ductal compartment. KRT19 depicted a dynamic pattern, 
fi rst located in the presumptive ductal territory at the LG epithelial germ stage, before 
getting restricted to the luminal side of the ducts in later stages (see study I, fi gure 8, 9 and 
S6). 
I used an ex vivo culture method (Munne et al. 2013) to investigate LG epithelial 
germ extension (fi gure 11; see study I, fi gure 8). Th e study revealed that KRT19+ cells 
form a spring-like shape structure in the elongated bud which dissipated aft er the fi rst 
branching event. Interestingly, an observation of Krt17-GFP embryonic LGs revealed a 
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similar expression pattern in the ductal territory (unpublished data). Krt17-GFP transgenic 
animals could be used with live imaging to study the mechanical forces at play during LG 
duct early morphogenesis, and the benefi t of the spring-like shape territory.
As a summary, the fi rst part of my work was dedicated to the characterization of gene 
expression patterns in order to set up a tool box to study LG biology. Th e studied genes 
included Acta2, Krt19 and Krt14.
Notably, we pinpointed Krt14 as a marker for the epithelial basal cell layer, establishing it as 
an interesting candidate to follow LG epithelium expansion. Using Krt14 promoter-driven 
recombinase in association with the R26R-Tdtomato reporter line (table 1), I observed the 
embryonic and postnatal LG morphological changes. I noticed a constant increase in LG 
size from P0 to P50, with a major outgrowth occurring between P7 and P13 (fi gure 12).
Th is last observation directed me to investigate the growth of LG epithelial 
compartment.
4.2.  Growth/expansion of the embryonic epithelium (study I)
4.2.1.  Tubulogenesis and branching 
Ductal formation, or tubulogenesis, is associated with lumen formation. Th is mechanism 
can occur through cell death (Wells and Patel 2010). I used cleaved-Caspase 3 (Casp3) 
staining and showed that LG lumen formation involved luminal cell apoptosis. In contrast 
to a previous report (Wang et al. 1995), I found that the lumen began to form early on 
during LG embryonic development. Specifi cally, the fi rst apoptotic cells were detected at 
E16. At E17, numerous microlumens were observed in the ducts, and by E18, they fused to 










Figure 11: Early formation of the ductal compartment. Surface 
rendering show that Keratin 19 protein (KRT19) is localized in the 
presumptive ductal territory prior to branching morphogenesis. Ex 
vivo cultures of E15 LGs reveal that KRT19 is restricted to a small 
area in the pre-bud. During the elongation period, KRT19+ cells 
adopt a spring-like 3D-conformation which is confi rmed in in vivo 
elongating bud. Th e spring-like shape gets disrupted aft er the fi rst 
branching event. Scale bars: 100 μm.
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form the lumen in the larger ducts. At this later stage, the remaining apoptotic cells were 
scarce (see study I, fi gure 7).
I used KRT19 immunostaining as a tool to follow branching morphogenesis. 
3D-surface rendering allowed me to determine the number of branching events along with 
the number of TEBs at each embryonic stage during LG ductal tree expansion. Notably, 
I found that from E16 to E18, both the number of branching events and the number of 
TEBs increased (see study I, fi gure 10). While the increase of both branches and TEBs was 
coherent with general growth of the organ, it raised questions regarding the mechanisms 
involved in ductal tree expansion. Th erefore, I studied LG cell proliferation dynamics.
4.2.2.  Proliferation 
To understand LG growth, I analysed the cell cycle status in LG development. I used 
phospho-histone 3 (phospho-H3) immunostaining and the Fucci transgenic mouse line 
(Sakaue-Sawano et al. 2008) to assess cell proliferation during LG embryonic development. 
Th e Fucci mouse line depicts proliferative cells (S/G2/M) with green fl uorescence and 
non-proliferative cells (G0/G1) with red fl uorescence. As the mesenchymal compartment 
was mainly non-proliferative, I used phalloidin staining to visualize the diff erent LG 
compartments and specifi cally quantify epithelial proliferation. 
At E15, the whole epithelial bud was globally proliferating. Th erefore, I focused on 
branching morphogenesis, from E16 to E18. My results revealed that cell proliferation 
rapidly undergoes a restriction to the acinar domain (mostly in suprabasal cell layers) aft er 
the fi rst branching event. Indeed, I noticed that LG ductal compartment gradually appeared 
non-proliferative. For this reason, I focused on quantifying cell proliferation in the TEB 
domain. Despite few cells remaining in an active cell cycle throughout LG embryonic 
morphogenesis, a large part of the cells exited the cycle by E18. Th e quantifi cation of these 
results revealed that while more than half of the cells were proliferating at E16, this number 
dropped to roughly 40% at E17, and 30% at E18 (see study I, fi gure 5). 
Although suprabasal cell proliferation fuelled LG early morphogenesis, the percentage 
of cells in an active cell cycle overall progressively decreased. Nevertheless, I reported a 
constant LG epithelium growth in embryonic stages (fi gure 12), and an important 
outgrowth of LG epithelium in postnatal stages (fi gure 12). Th erefore, I investigated 
alternative mechanisms which could contribute to ductal tree expansion and LG general 
growth.
4.2.3.  Cell intercalation and MET 
To go further, I used genetic fate mapping to decipher the cellular events engaged in 
branching morphogenesis and epithelial territory patterning. By using a constitutive Krt14 
promoter-driven recombinase (Krt14-cre43) in association with R26R-Confetti, -mT/mG 
and -TdTomato reporter lines (see table 1), I followed Krt14+ cells clonal expansion. 
Th e Confetti construct is a Cre recombinase fl uorescent reporter containing two 
dimers segments, each one encoding for two colours. Upon recombination, the Confetti 
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construct can randomly generate four possible colours. Th e use of a constitutive Cre 
recombinase results in a continuous inversion of the dimer left  aft er the fi rst recombination 
event, cleaving away one of the two dimers. Th erefore, as long as the recombinase is 
active, the cell can continuously switch back and forth from GFP to YFP, or from RFP 
to CFP (see study I, fi gure S4). R26R-Confetti ex vivo cultures revealed a mix of the four 
possible fl uorescent dyes imaged, i.e. GFP, CFP, RFP, and YFP (fi gure 12). As I used a 
Figure 12: Embryonic and postnatal LG epithelium expansion. (A) External views of in vivo 
K14-Cre43;R26R-Tdtomato postnatal animals show LG epithelial compartment morphological 
changes from P0 to P50. Th e LG undergoes an important epithelial expansion between P7 
and P13, period of eyelid opening in mouse, and continues its growth until P50.  (B) External 
views of in vivo Krt14-Cre43;R26R-Tdtomato embryos depict LG epithelial compartment 
morphological changes from E15 to E18. Th e LG bud is not branched at E15 but from E16 
onwards, branches develop. At E17 the intra-orbital lobe (IOL) starts to form (upper panel). Th e 
use of Krt14-Cre43;R26R-Confetti in ex vivo cultures (from E15 to E15+3 days of culture) shows 
the involvement of epithelial cell rearrangement during LG branching morphogenesis. Th e 
representation of three possible colours with surface rendering demonstrate the intercalation of 
Keratin 14 (Krt14) positive clones from diff erent origins. Indeed, in all stages, single Krt14+ cells 
of one colour can be observed intercalated in a domain of another colour (white arrowheads, 





























































constitutively active recombinase, I separated the recombined cells into two domains, 
corresponding to the GFP-YFP (arbitrary represented in orange) and the RFP-CFP (in 
violet) cell populations. I did not detect the formation of vast territories during branching 
morphogenesis, as I could have expected from a proliferating and expanding epithelium. 
Rather, aft er three days of culture, I showed that the TEB basal layer is formed from series 
of small orange and violet domains (see study I, fi gure 6A). Th us, my study suggested a 
continuous cell intercalation process, off ering a faster elongation mechanism as previously 
reported in branching epithelia (for review, (Wang et al. 2017)). Moreover, single Krt14+ 
clones could also be visualized at this point.
Strikingly, I detected non-recombined cells when using the constitutive Cre in 
association with any of the three above mentioned reporter lines. In the R26R-Confetti 
and -TdTomato lines, this resulted in unlabelled cells. We ruled out the possibility of a 
low recombination effi  ciency by immunolocalizing KRT14 in Krt14-cre43;R26R-mT/mG 
samples (see study I, fi gure 6B and S5). In this combination, the recombined cells express 
GFP and other cells Tomato at the membrane. We found KRT14 negative cells which did 
not undergo the recombination process in the epithelial compartment (red cells). As Krt14-
cre43 recombinase is active early on in the development (Andl et al. 2004), I hypothesized 
that these cells could arise from Krt14 negative origin. 
Cell intercalation has been associated to MET in kidney morphogenesis (Campbell 
et al. 2010; Carroll and Das 2013). Th is process involves mesenchymal cells adopting an 
epithelial phenotype and invading a nearby epithelium. Th e transition requires a change 
in several gene expression, such as the induction of Ecad expression (Vanderburg and Hay 
1996). From E16 to E18, I distinguished few positives mesenchymal cells in close contact 
to the epithelial basal cell layer. Moreover, these cells seemed to intercalate within the 
epithelial compartment during branching morphogenesis. ECAD staining at E16 showed 
few ECAD+ mesenchymal cells in similar locations (see study I, fi gure 6C). MET was 
previously suggested in the LG context (Dean et al. 2004), but my results gave the fi rst 
evidence of MET involvement during LG morphogenesis. 
4.3.  Signalling pathways in LG biology (study I and III)
4.3.1.  Notch pathway (study I)
4.3.1.1.  Expression of Notch pathway elements in LG
Notch pathway was previously involved in salivary gland acini formation (Garcia-
Gallastegui et al. 2014) and cell diff erentiation in other branching organs (Tsao et al. 2008). 
My transcriptomic analysis revealed an enrichment of diff erent Notch pathway elements 
in embryonic LG compared to adult LG (see study I, fi gure S7A and B). Among them, the 
receptors Notch1 and Notch3 were more expressed in embryonic LG (4.9 and 4.17 fold 
respectively) and Notch2 was signifi cantly expressed both in embryonic and adult LGs. Th e 
target gene Hey1, numerous Adam (Notch receptor associated proteins) and Dlk1 were also 
enriched in embryonic LG (45.29 fold for Hey1, 79.86 fold for Dlk1). Notably, Dlk1, a Notch 
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ligand implicated in the non-canonical pathway, was recently reported as involved in LG 
embryonic development (Dvoriantchikova et al. 2017).
I analysed the expression of numerous Notch pathway elements by RT-PCR and 
observed a dynamic expression of Notch pathway related genes. Additionally, RT-qPCR 
for Notch2 and Hey1 confi rmed the expression of both genes during LG morphogenesis, 
from E15 to E18. Notch2 expression was low during the early phases of LG formation, 
but increased by E18, reaching its highest expression levels in adult LG. Hey1 expression, 
refl ecting Notch pathway activation, was overall steadily expressed. However, I could 
observe a peak of Hey1 expression at E16, along with the start of branching morphogenesis 
(see study I, fi gure S7C). Th ese results, in association with the previous report on Notch1 
(Dvoriantchikova et al. 2017), pointed towards the involvement of diff erent Notch receptors 
to activate Notch pathway during LG formation. 
I studied the localization of NOTCH2 and JAGGED1 (one of NOTCH2 ligand) by 
immunohistochemistry and found that both proteins were localized in the epithelium 
from E15 to E18 (see study I, fi gure 11). Moreover, I targeted NOTCH2 intracellular 
domain (ICD), cleaved and translocated to the nucleus upon NOTCH2 activation. Cleaved 
NOTCH2 was mainly found during branching morphogenesis, both in the TEBs (basal 
and suprabasal layers) and in the ductal territory. Although NOTCH2 activation seemed to 
have a specifi c time window, its expression levels seemed to be uncorrelated to its level of 
activation, as the RT-qPCR analysis revealed a higher Notch2 expression at E18 and at the 
adult stage. It would be interesting to study Notch2 cleavage in the adult stage. 
Particularly, the enrichment in Notch target gene Hey1, along with the 
immunolocalization of NOTCH2 ICD specifi cally pointed towards an active Notch 
pathway in the epithelial compartment of embryonic LG. Th erefore, I investigated Notch 
pathway role in LG early formation. 
4.3.1.2. TEB territory establishment and maintenance 
To decipher the role of Notch pathway in LG morphogenesis, I inhibited Notch pathway 
activity in ex vivo cultures, using a γ-secretase inhibitor (DAPT) treatment. Notch pathway 
inhibition was confi rmed by RT-qPCR analysis for Hey1 expression, downregulated upon 
DAPT addition in the ex vivo cultures. Immunohistochemistry staining for NOTCH2 ICD 
also revealed a drastic reduction upon DAPT treatment (see study I, fi gure S7D and E). 
I found that Notch pathway inhibition induced the formation of holes within the TEBs, 
already aft er 24 hrs of treatment (when compared to DMSO treated control glands). 
Th e hollowed TEB phenotype was maintained as long as Notch pathway inhibitor was 
present and was rescued as early as one day aft er DAPT removal (fi gure 13). I performed 
immunohistochemistry against cleaved Caspase3 and showed that TEB suprabasal cell loss 
occurred via apoptosis, as previously described in salivary gland ex vivo cultures treated 
with DAPT (Garcia-Gallastegui et al. 2014) (see study I, fi gure S8). Strikingly, LG ex vivo 
cultures were capable of rapid regeneration upon DAPT treatment removal. Th is phenotype 
was associated with extra-branching, as recently described (Dvoriantchikova et al. 2017), 
which was maintained aft er DAPT removal (see study I, fi gure 12). 
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I investigated further this phenomenon and showed an increase in Acta2 expression 
aft er 4 days of culture, both by RT-qPCR and SMA immunohistochemistry (see study 
I, fi gure 13B and S9). Th is was correlated with a reduced ductal tree expansion and a 
diminution of KRT19+ cells (see study I, fi gure 13A). Notch inhibition induced a switch in 
territory identity as previously described in lung development (Tsao et al. 2008), extending 
the TEB territory to the branches. Th ese results pointed towards a role for Notch pathway 
in TEB patterning.
To summarize, I identifi ed a novel role for Notch pathway in LG for the TEB 
maintenance and territory establishment. Notch pathway inhibition induced suprabasal 
cells reversible loss and maintained extra-branching, suggesting a switch of cell identity 
from ductal to acinar fate.
E15 E15+1d E15+2d E15+3d E15+4d
Medium + DAPT 10μM  treatment
Normal medium
Medium + DMSO
Medium + DAPT 10μM treatment
Figure 13: Eff ect of Notch signalling inhibition in LG ex vivo cultures. Th e inhibition of 
Notch pathway with DAPT treatment (10 μM) induces the loss of TEB suprabasal cell layers and 
extra-branching in LG ex vivo cultures. Upper panel demonstrates the normal LG development 
in DMSO-treated ex vivo cultures. Hollowed TEBs (green arrowheads) appear rapidly aft er 1 
day of treatment (middle and lower panel) and are maintained throughout Notch inhibition. 
When the inhibition is removed, hollowed TEBs are quickly regenerated, while extra-branching 
remains. Scale bars: 200 μm.
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4.3.2.  Eda pathway (study III)
Eda loss-of-function mutation results in MGs defi ciency. Th erefore, Eda pathway was 
previously implicated in DEDs. However, its role on LG biology was so far disregarded. 
I performed an RNA sequencing analysis to compare control and Eda loss-of-function 
(Eda-/-) LG transcriptomes in adult mice and found that 3% of Eda-/- LG transcriptomic 
signature was diff erent from the control one. Th ese results already demonstrated that Eda 
pathway has some impact on LG biology. Th erefore, I decided to investigate the role of Eda 
pathway in LG development, maturation and function. 
In this part of the project, I took advantage of four mutant mouse strains: Eda-/- loss-
of-function (tabby) mouse, Krt14-Eda and Krt14-Edar mice, exhibiting a forced expression 
of Eda and Edar in Krt14+ cells respectively, and NF-B-gal transgenic model, reporting 
for Eda pathway activity (see table 1).
4.3.2.1.  Role of Eda signalling in LG development
I used the RNAscope technology (Wang et al. 2012) to determine Eda and Edar localization 
during LG early formation from E16 to E18. I demonstrated that Eda and Edar have 
opposite, although partially overlapping, expression patterns during LG formation. Eda 
was mostly expressed in LG mesenchyme, while Edar was mainly restricted to the epithelial 
compartment (see study III, fi gure 1A). In addition, I used the NF-B-gal reporter to 
study Eda pathway activity. In agreement with Edar expression pattern, I showed that Eda 
pathway was only active in LG epithelium. Although Eda pathway was broadly active both 
in basal and suprabasal cell layers, the activity seemed stronger in the basal cell layer. By 
E18, cells exhibiting an active Eda pathway were scattered in the epithelial compartment, 
progressively restricted to the acinar compartment (see study III, fi gure 1B).
I took advantage of our previously reported methods to study the ductal tree 
expansion, TEB formation and proliferation status during LG embryonic development 
(study I). Although Eda loss of function had a variable impact on LG global morphology, 
I reported that Eda-/- mutant TEB number and ductal tree volume were similar to control 
during branching morphogenesis. Nonetheless, quantifying TEB cell proliferation revealed 
an increased number of phospho-H3+ cells in Eda-/- compared to controls at the end of 
embryonic morphogenesis (1.25 fold at E18). Th erefore, although the number of TEB was 
consistent in control and mutants, there was no obvious correlation between this parameter 
and the TEB proliferation status (see study III, fi gure 3).
Finally, I characterized the phenotype of Krt14-Eda and Krt14-Edar mutants, in which 
Eda pathway is forced in Krt14+ cells. As a reminder, Krt14 expression becomes restricted 
to the basal cell layer during LG embryonic development (study I). I could this way assess 
the consequences of Eda pathway misregulation in LG epithelium. Using the NF-κB-gal 
reporter, I studied Eda activation pattern in these mutants. Th e forced expression of Eda 
ligand led to a broader activation of Eda pathway in LG epithelium, but not to any major 
morphological impact (see study III, fi gure 2). Krt14-Eda mutants displayed a ductal tree 
volume similar to control. Nevertheless, Krt14-Eda LGs showed an increased proliferation 
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in the TEBs at both E17 and E18 (1.46 fold and 1.2 fold respectively), but a reduced TEB 
number at E18 (0.68 fold) (see study III, fi gure 3).
Conversely, Krt14-Edar mutants exhibited a reduced Eda activity and a delayed 
starting point in branching morphogenesis. However, this delay had no major impact on 
the proliferation status, ductal tree expansion, nor on the number of TEBs as Krt14-Edar 
LGs were similar to the control morphology by E18 (see study III, fi gure 2 and 3). 
Eda activity was diff erently patterned in Krt14-Eda and Krt14-Edar mutants, possibly 
due to Eda and Edar forced expression in a restricted cell population. However, it is 
interesting to highlight that the global LG morphology remained similar to the control one 
by the end of embryonic development. I concluded that there was a possible implication, 
however limited, of Eda pathway activity on LG early morphogenesis.
4.3.2.2.  Role of Eda signalling in LG maturation
NF-B-gal staining revealed an active Eda pathway in postnatal LG (P21), as well as in the 
adult (34 wo) (see study III, fi gure 1B). 
I studied LG maturation in the three mutants by evaluating the expression level of 
previously reported cell terminal diff erentiation markers. I used Acta2 for the MECs; 
Ltf, BhlhA15 and Aqp5 for the acinar compartment and Krt19 and Slc12A2 for the ducts 
(Farmer et al. 2017) (see study III, fi gure 4). 
Eda loss-of-function mutation led to an alteration of cell terminal diff erentiation, 
revealing an impaired maturation process. From P0 to P21, acinar specifi c genes exhibited 
an almost constant upregulation in Eda-/- mutant compared to control LGs (Ltf: 3 fold; 
BhlhA15: 1.5 fold and Aqp5: 2 fold at P21). In contrast, although ductal markers did not 
display strong expression changes from P0 to P13, both Krt19 and Slc12A2 were upregulated 
at P21 (4 fold and 1.45 fold respectively). Lastly, while Acta2 was enriched in the mutant at 
P0, Eda-/- LG exhibited a reduced Acta2 expression at P13 (0.75 fold).
I studied the maturation process in the two gain-of-function mutants (Krt14-Eda and 
Krt14-Edar). Duct and MEC specifi c genes were expressed in a similar pattern in both 
mutants. From P0 to P13, duct specifi c genes were downregulated or close to control values. 
However, at P21, both Krt19 and Slc12A2 were generally upregulated in both mutants 
compared to control (Krt19: 5.5 fold and Slc12A2: 1.25 fold for Krt14-Eda; Slc12A2: 1.55 
fold for Krt14-Edar). Moreover, in both mutants and at all stages, Acta2 was less expressed 
or close to the control level of expression. Finally, acinar specifi c genes exhibited a less 
sustainable expression pattern. In both mutants, Aqp5 was downregulated from P0 to 
P13, but enriched at P21 (1.57 fold for Krt14-Eda and 1.22 fold for Krt14-Edar). BhlhA15 
expression was similar to control or upregulated between P0 and P21 (1.9 fold for Krt14-
Eda at P21). Conversely, only Ltf expression depicted a diff erential expression between 
Krt14-Eda and Krt14-Edar mutants. In Krt14-Eda, Ltf was only enriched compared to 
control at P21 (1.8 fold), while in Krt14-Edar, this gene was downregulated at P0 (0.38 
fold), but similar to control aft er this stage.
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In summary, both forced activation and inhibition of Eda pathway led to an increased 
expression of diff erentiated acinar and ductal specifi c genes by P21. At this stage, however, 
the MEC compartment was not aff ected by Eda pathway modulation. Th e gene expression 
modulations were more striking in Eda-/- than in the gain-of-function mutants, Krt14-Edar 
mutant being the least diff erent from the wild type LG. 
As mentioned above, we demonstrated that Krt14+ cells were mainly distributed in 
the basal cell layer from the start of branching morphogenesis (study I). Krt14-Eda and 
Krt14-Edar therefore respectively overexpressed Eda and Edar predominantly in the basal 
cell layer. One hypothesis was that the overexpression of Eda ligand in Krt14+ cells led 
to the saturation of all accessible receptors in those cells. As endogenous Eda ligand was 
mainly found in the mesenchymal compartment, the overexpression of Edar receptor in the 
Krt14+ cells could lead to a similar outcome by intercepting all Eda ligand available in the 
surrounding mesenchyme. In both situations, the abnormal activation of Eda pathway in 
Krt14+ cells could lead, based on the Gierer and Meinhardt model (Gierer and Meinhardt 
1972; Babloyantz and Hiernaux 1975), to short-range activation of the pathway, and long-
range lateral inhibition. In fi ne, this would result in the overall diminution of the pathway 
activity mainly in the suprabasal cell layers in Krt14-Eda and Krt14-Edar mutants. Eda-/- 
mutants present the lowest level of Eda signalling possible, both in basal and suprabasal cell 
layers. 
A second hypothesis could involve a third party, such as the Troy pathway, previously 
shown to act in a redundant way to Eda signalling in hair development (Pispa et al. 2008), 
or EDA2R, for which the biological implications remain to be clarifi ed.
Th is could bring possible explanations for the similar outcomes arising from the 
three diff erent mutations. It was previously suggested that a deregulation of normal Eda 
pathway activity could lead to instabilities in developmental processes (Kangas et al. 2004). 
Indeed, it was reported that both Krt14-Edar and Eda-/- mutations lead to similar molar 
phenotypes in the mouse, associated with polymorphism (Pispa et al. 2004; Tucker et al. 
2004). Gain- and loss-of-function of Eda pathway have opposite outcomes in salivary gland 
development: Eda-/- salivary glands depict fewer branches while Krt14-Eda salivary glands 
have signifi cantly increased branches number (Haara et al. 2011). In the case of LG it seems 
that any modifi cation of Eda pathway activity led to similar postnatal maturation defects.
I decided to focus on the loss-of-function mutation and used RNA sequencing to 
compare Eda-/- and control LG transcriptomes in adults (13 wo). Th e analysis highlighted 
signifi cant changes in Eda-/- gene expression profi le when compared to control: 2% of the 
transcripts were downregulated, while 1% was upregulated in Eda-/- LG (see study III, 
fi gure 6). I validated the analysis by RT-qPCR and confi rmed that Wnt4, reported in the 
study of diff erent glands (Brisken et al. 2000), and Lin28a transcripts were less abundant in 
the mutant (0.26 fold and 0.01 fold respectively). Interestingly, Lin28a has been reported to 
promote tissue repair (Shyh-Chang et al. 2013) and to positively regulate SC metabolism 
(Zhang et al. 2016). In contrast, Esp34 and Dgat2 were more expressed in Eda-/- LG (over 8 
fold and 84 fold respectively). 
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To summarize, all my results pointed towards a defective LG maturation upon 
modifi cation in signalling activity. Moreover, the defects remained in Eda-/- LG at 
adult stage, as up to 1773 transcripts were misregulated in Eda-/- LG. Proper terminal 
diff erentiation is crucial for physiological LG secretion. Th erefore, I studied LG function in 
Eda loss-of-function mutants. 
4.3.3.  Other signalling pathways (study I)
Wnt pathway is known to negatively regulate LG branching (Dean et al. 2005). Similarly 
as in the SMG development where Wnt and Eda pathways act in a positive feedback 
activation loop (Haara et al. 2011), both pathways seem to depict opposite activity patterns 
in LG morphogenesis (study III and (Dean et al. 2005)). Th erefore, it is possible that the 
implication of Wnt pathway in LG development is complex, involving a fi ne tuning of its 
activity and a communication between mesenchyme and epithelium.
My microarray analysis revealed an enrichment of Wnt elements expression during 
LG formation. Notably, I noticed an upregulation of Fat1 and Fat4, two components of the 
noncanonical PCP pathway (6.34 fold and 67.7 fold respectively) and of three Wnt pathway 
inhibitors (namely Sfrp1 (71.39 fold), Dkk2 (60.5 fold) and Dkk3 (18.87 fold)). I performed 
the study on whole LGs (both epithelium and mesenchyme) and the activation/inhibition 
experiments described by previous authors mainly recapitulate the involvement of Wnt 
pathway in LG embryonic epithelium (Dean et al. 2005). Th erefore, it would be interesting 
to assess the expression of Wnt pathway elements in mesenchymal versus epithelial 
compartments in embryonic LG, and to specifi cally investigate the role of Wnt pathway in 
LG mesenchyme.
4.4.  LG physiological func  ons (study II and III)
4.4.1.  Dry eye disease 
Eda-/- mutant is an established dry eye model. However so far, the symptoms are categorized 
as evaporative, due to meibomian glands defi ciency (Wang et al. 2016). I confi rmed dry eye 
symptoms by assessing the blinking rate for three adult ages, ranging from 13 to 64 wo. I 
revealed a striking increase in the number of blinks per minute in the mutants compared 
to the controls (from 6 to 12 fold depending on the age group). At any stage, however, 
gain-of-function mutants did not display a diff erent blinking rate from the control one. In 
the case of the loss-of-function mutation, the diff erence was the highest at 13 wo (12 fold). 
Th erefore, I measured the tear production and established that Eda-/- mutants secreted less 
tears than the controls at 13 wo (0.38 fold) (see study III, fi gure 5). LG encounters for the 
majority of the tear fl uid and together with my previous results, this pointed towards a 
defective LG function in Eda-/- mutants. Th erefore, I hypothesized that the aetiology of 
Eda-/- mutants’ dry eye directly involved the LG. Th is would establish the Eda-/- mouse 




In addition, the RNA sequencing results highlighted a misregulation of particular 
growth factors produced by the LG in the tear fl uid. Egf was not diff erently expressed in 
Eda-/- compared to control LGs. However, RT-qPCR analysis confi rmed the downregulation 
of Fgf7, Igf1, Hgf and Tgfb 1 expression levels in Eda-/- LGs (0.48 fold, 0.33 fold, 0.73 fold 
and 0.34 fold respectively) (see study III, fi gure 7C). All four genes were reported to act 
on corneal epithelium maturation and/or maintenance during homeostasis among other 
functions (for review, (Klenkler et al. 2007)). Notably, IGF-1 can be found in the tear fi lm 
and IGF-1 receptor is present in the corneal epithelium (Rocha et al. 2002). A recent study 
on human subjects revealed the high concentration of IGF-1 in the tear fi lm of young 
adults, and its decrease in elderly. Th is was associated with dry eye symptoms in older 
adults (Patel et al. 2018). 
In contrast, Gdf5 and Cxcl10 were more expressed in Eda-/- LG (14 fold and 1.2 
fold respectively) (see study III, fi gure 6C and 7C). Gdf5 was previously involved in the 
inhibition of corneal epithelial cells proliferation (You et al. 1999), and decreased cell 
proliferation was reported in Eda-/- corneas (Li et al. 2017). GDF5 has also been reported 
to induce angiogenesis on the cornea (Yamashita et al. 1997), known to alter visual acuity 
by aff ecting corneal transparency (for review, (Maddula et al. 2011)). Moreover, increased 
concentration of CXCL10 in the tear fi lm has been associated with DEDs (Yoon et al. 2010).
Nonetheless, impaired cornea wound healing was observed in Eda-/- animals. Th ese 
defects were so far attributed to severely aff ected MGs (Wang et al. 2016). 
4.4.2.  Cornea wound healing
In normal conditions, the tear fi lm is responsible for the maintenance of the CE homeostatic 
state. Upon eye surface injury, the protein composition can tremendously vary both 
qualitatively and quantitatively to support the recovery of the corneal integrity (for review, 
(Klenkler et al. 2007)). Several techniques are available to study wound closure in mouse 
models. Chemical burns usually aff ect both CE, stroma and the surrounding conjunctiva 
(Bai et al. 2016), and oft en lead to severe outcomes (Bai et al. 2016). Other techniques rely 
on mechanical disruptions of the eye surface. Th ose include the use of blades or sharp 
objects and commonly penetrate through the stroma (Blanco-Mezquita et al. 2011; Blanco-
Mezquita et al. 2013). 
In the study II, we described a reliable method to in vivo abrade a delimited region of 
the CE without disrupting the basal membrane and the underlying stromal compartment. 
Th is technique of CE debridement was fi rstly elaborated using blades on ex vivo corneas 
(Gipson and Kiorpes 1982). In our protocol, the use of an ocular burr permitted to 
strictly delimit the injury area to the CE in a reproductible manner (see study II, fi gure 
1). Th e resulting wound resembled the most common corneal abrasion found clinically in 
human (Jackson 1960). We followed the corneal wound healing process with fl uorescein 
staining and described the timeline of full recovery. At 18 hrs post wound, the wound was 
remarkedly diminished in size and we found that already aft er 72 hrs, the CE was fully 
re-epithelialized (see study II, fi gure 3).
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I hypothesized that the defective response of Eda-/- LG described in the study III 
participates to the impaired cornea wound healing process and further investigated LG 
response to corneal injury, using the established CE abrasion protocol.
4.4.3.  Cornea repair in dry eye context
I confi rmed the delayed healing process by using our corneal abrasion model (study II) and 
followed CE closure with fl uorescein staining (see study III, fi gure S2). Since we recently 
reported an active healing state at 18 hrs post wound in the cornea (Kalha et al. 2018b), 
we used this time point to study the impact of the injury on Eda pathway activity. As 
recombinant EDA supplementation was reported to be benefi cial for CE regeneration (Li et 
al. 2017), I fi rst studied Eda pathway activity in the CE. Although I observed little expression 
of Eda and Edar in the embryonic CE, and high Edar expression in the adult cornea, no Eda 
pathway activity was detected in the control cornea at any stage (see study III, fi gure S3). 
In addition, I did not detect any activity before nor aft er the abrasion. However, NF-B-gal 
staining showed a complete inhibition of the pathway in the LG aft er the abrasion (fi gure 
14). Th is was confi rmed by RT-qPCR, revealing a striking downregulation of Eda and Edar 
expression 18 hrs aft er the abrasion in comparison to unwounded LGs (0.36 fold and 0.15 
fold respectively) (see study III, fi gure 7A and B). 
Eda pathway inhibition was extended to the contralateral LG, on the unwounded eye 
side. Th is last result confi rmed a cross-talk occurring between LG and cornea, but most 
importantly, tended to indicate a communication between the two LGs.
I followed Egf, Hgf, Tgfb 1, Igf1, Fgf7, Cxcl10, Mmp2 and Bmp1 expression 18 hrs aft er 
epithelial abrasion (see study III, fi gure 7C). LG factors secretion are known to change upon 
corneal insult and the modulation of the tear fl uid composition supports the wound healing 
process (Klenkler et al. 2007). Particularly, EGF tear concentration increases immediately 
at the time of wound but rapidly returns to basal levels one day aft er the injury (Sheardown 
and Cheng 1996). My results showed that although Egf expression was similar in pre and 18 
hrs post wound in the control LG, Egf expression was upregulated in post wounded Eda-/- 
samples compared to unwounded Eda-/- samples (1.14 fold). Th is could mean that Eda-/- LG 
defective function results in a delayed return to Egf basal levels.
HGF concentration has been reported to decrease one day post injury (Tervo et al. 
1997). My results depicted a reduced Hgf expression already aft er 18 hrs post abrasion in 
Eda-/- LGs only (0.75 fold). Similarly, it was shown that Tgfb 1 concentration is drastically 
reduced in human tears two days post cornea operation but is back to basal levels three 
months aft er (Tuominen et al. 2001). In contrast, I noticed a striking increase in Tgfb 1 
expression aft er cornea injury, both in control and Eda-/- LGs (2.77 fold and 5.1 fold 
respectively). 
Aft er cornea wounding, the IGF-1 present in the tear fi lm was linked to limbal SC 
diff erentiation, needed to support the healing process (Trosan et al. 2012). Contrastingly, I 
found that Igf1 expression was reduced 18 hrs aft er corneal abrasion in control LGs (0.31 
fold) but remained unaff ected in Eda-/- samples.
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Figure 14: Eda pathway is involved in corneal epithelium regeneration aft er abrasion. (A) 
NF-B-gal reporter is used to detect Eda activity in both corneal epithelium (upper row) and 
lacrimal gland (LG, lower row) samples at 13 wo during a cornea wound healing experiment. In 
unwounded controls, Eda pathway is active in the LG (black arrowheads). At 18 hrs post wound, 
Eda activity is not detected in either LGs, demonstrating a transmission of the injury signal to 
the bilateral LG, side of the untouched eye. Eda pathway is not active in the cornea, whether 
prior or aft er corneal abrasion. Scale bars: 100 μm. (B) Fluorescein staining is used to visualize 
the wounded region at the time of the wound (0 hrs post wound) and aft er 18 hrs, in control and 
Eda-/- animals. Following cornea wound healing reveals that at 18 hrs post wound, the impaired 
corneal area appears almost healed in control animals, while a consequent wounded area is still 
visible in Eda-/- mutants. Cornea wound healing is delayed in Eda-/- mutant compared to control. 
Th e red dotted line delimits the wounded area. 



























Fgf7 expression has been reported to increase upon cornea injury (Wilson et al. 1999). 
Disparagingly, I showed that Fgf7 was downregulated both in control and Eda-/- LGs aft er 
injury (0.36 fold and 0.21 fold respectively). 
I reported a decrease in Cxcl10 expression aft er corneal abrasion in Eda-/- samples (0.05 
fold). It was reported that Cxcl10 expression is induced upon wounding in mice. However, 
endogenous Cxcl10 expression increase is impaired in diabetic mice, which happen to 
also suff er from delayed cornea wound healing. Exogenous CXCL10 supplements can 
overcome this defect and support cornea restoration in diabetic mice (Yan et al. 2016). Th e 
downregulation of Cxcl10 expression in my model could participate to the delayed healing 
process observed in Eda-/- animals.
MMP2 concentration highly increases in the tear fi lm following feline cornea injury, 
as early as 8 hrs aft er the wound (Petznick et al. 2013). Th e presence of this protease in the 
tear fi lm seems to improve the healing process (Ollivier et al. 2007). I did not fi nd similar 
results, as Mmp2 expression was reduced both in control and Eda-/- LGs aft er the abrasion 
in our analysis (0.47 fold and 0.64 fold respectively).
Finally, Bmp1, a protease previously reported as support for the corneal wound 
healing, was shown to be upregulated in mouse corneal epithelium 7 days aft er wounding 
(Malecaze et al. 2014). In contrast, I noticed a drastic inhibition of Bmp1 expression both 
in control and Eda-/- LGs 18 hrs aft er wounding (0.06 fold and 0.1 fold respectively). Th is 
inhibition could be transient and preceding the augmentation in the later stages of corneal 
healing.
Importantly, it needs to be pointed out that the gene expression diff erences observed 
in my study compared to previously published results could be due to the 18 hrs time point 
chosen in my study.
As a conclusion, although Eda-/- LG is able to modulate its secretion upon corneal 
injury, the regulation is abnormal and diff erent to the control. Together, this could lead 
to the observed delay in CE wound healing. Previous reports demonstrated that epithelial 
wound healing follows numerous steps (Petznick et al. 2013). To go further, it would be 
crucial to measure the above-mentioned gene expression dynamics across the wound 
healing process, from the wounding time to three days post wound, when the CE is fully 
restored (Kalha et al. 2018a). 
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5.   CONCLUDING REMARKS AND FUTURE 
PERSPECTIVES
Instrumental to corneal health and therefore to clear vision, the LG has extensively been 
studied in its pathological conditions, looking through the prism of proper eyesight 
maintenance. Considering the increasing prevalence of DEDs, solid basic knowledge is 
required to successfully apply regenerative medicine in future therapies. Th e fundamental 
directives followed by embryonic tissues, in order to form the fully functional LG biological 
system from the conjunctival epithelium remain rich in mysteries. 
In my work, I participated in enhancing the general knowledge on LG morphogenesis 
and maturation processes, together leading to the proper function of the organ and 
production of potent tears. 
Notably, my work contributed to delineate the crucial role of Notch pathway in acinar 
territory boundaries formation and maintenance. Th e Notch aspect of my work was 
mainly focused on embryonic development and showed that transient inhibition of Notch 
signalling leads to suprabasal cell loss, rapidly regenerated aft er inhibition removal. Notch 
pathway was reported to play a role in kidney regeneration (Ma et al. 2018). It would be 
interesting to study further the involvement of Notch in adult LG maintenance and repair. 
Previous studies suggested a role for Eda pathway in LG biology (Grüneberg 1971; 
Kowalczyk-Quintas et al. 2015), but the striking MGs atrophy in Eda loss-of-function 
mutants (Grüneberg 1971; Wang et al. 2016) had so far led to ignore and side-line the 
LG phenotype. In my studies, I investigated Eda signalling implication in LG formation, 
maturation and function. In light of my results demonstrating acinar and ductal 
compartments maturation defects in Eda-/- LG, I suggested a new paradigm on Eda-/- dry 
eye, alternative to the current evaporative theory. I hypothesize that Eda-/- dry eye results 
in the combination of multiscale defective lacrimal apparatus components. Together, this 
further highlights the need for a fi nely integrated regulatory network.
To test my hypothesis, I could inject EDA recombinant proteins in adult LG. Together 
with LG high regenerative potential (Zoukhri et al. 2008), it would be interesting to see if it 
is possible to compensate Eda-/- defective maturation and restore an adequate LG secretion. 
XLHED was previously rescued by postnatal injection of EDA in dog (Casal et al. 2007), 
and recombinant EDA supplementation have been reported to ameliorate Eda-/- dry eye 
symptoms (Li et al. 2017).
Lot of eff orts have been put into the development of topical eye drops. In this thesis, 
I highlighted the fl uctuation of previously reported growth factors involved in cornea 
wound healing (Klenkler et al. 2007). In this perspective, following the dynamics of 
these growth factors during corneal wound healing, from the time of the wound until 
the complete recovery will most certainly spotlight new factors in play. Subsequently, 
specifi c growth factors could be used for the development of customizable artifi cial tear 
substitutes containing all the essential tear components for a faster and most effi  cient CE 
regeneration. However, the techniques used in my thesis rely on transcriptomic dynamic 
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changes, implying that the changes observed in gene expression are mirroring the protein 
concentrations in the tear fi lm. More eff orts on proteomic assessments should be carried 
out in the future, to potentialize the tear substitute and address the required factors to each 
recipient organ.
One problem is the low retention of the drugs delivered on the eye surface. Commonly, 
any delivered component on the eye is cleared away within three hours. To overcome the 
low retention time, engineered nanoparticles and microparticles are developed (for review, 
(Ravi Kumar 2000)). Among them, mucoadhesive nanoparticles were reported to increase 
the ocular retention (Liu et al. 2016), and other microsphere were formulated to create 
a gel on the ocular surface (Albertsson et al. 1996) It would be interesting to combine 
bioengineered molecules with artifi cial tear substitutes. Th ese artifi cial tears could be tested 
on the extra-orbital lobe removal model (Shinomiya et al. 2018), together with our ocular 
wounding protocol.
Lastly, the use of our well-established CE abrasion method, together with the Eda 
pathway reporter mouse line led to the confi rmation that both LG and cornea function 
together to transmit distress signals from one eye to the other and permit a faster healing 
process of both eyes (fi gure 15).
To conclude, the outcome of my research could help to the development of new 
therapeutic strategies aiming at improving the ocular surface condition, both in 
physiological, aging and wounded situations.
Figure 15: Th e cornea-LG feedback loop. Th e communication occurring between the lacrimal 
apparatus and the cornea leads to the adjustment of the tear fi lm composition aft er CE injury or 
stress signal from the ocular surface.
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J’aimerais dédier cette thèse à Mamie Bus, qui me sourirait avec bienveillance et prétendrait 
comprendre mon charabia. 
I am dedicating this dissertation to my grand-mother who would smile with kindness and nod 
at me pretending she understands my gibberish.
As a child, I did not dream of becoming a Scientist.
In early school, I was surrounded by an environment promoting other kind of greatness. 
My friends wanted to become teachers, veterinarians or nurses. As for me, I was fascinated 
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the highest educational path in my mind and curing people the highest reward. 
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being able to derive happiness from discovery is a recipe for a beautiful life.”
        Hope Jahren, Lab Girl (2016)
Fixing symptoms is one way to bury causes, but isn’t it better to understand the origins of 
problems and prevent them from happening? Using a diff erent metaphor, would you try to 
fi x a television without knowing what makes it function in the fi rst place? 
I have great expectations on the evolution of children’s awareness concerning the multitude 
of possibilities that the world off ers. Let them know that failure is part of the process, and 
that failure brings new opportunities for discovering one’s true self. Let them know that 
veterinarian is not the only path to contribute to animal care, and that failing in one domain 
does not close doors but rather opens more. Let them know how great their mind is, how 
smart and imaginative they can be and how these are the most valuable characteristics that 
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always there for me when I needed it. Coming from a recomposed household, I know that 
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whom time and distance does not change the invisible connection that is reactivated once 
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